Contractual Expansion of the Scope of Patent Infringement through Field-of-Use Licensing by Patterson, Mark R.
Fordham Law School
FLASH: The Fordham Law Archive of Scholarship and History
Faculty Scholarship
2007
Contractual Expansion of the Scope of Patent
Infringement through Field-of-Use Licensing
Mark Patterson
Fordham University School of Law, mpatterson@law.fordham.edu
Follow this and additional works at: http://ir.lawnet.fordham.edu/faculty_scholarship
Part of the Comparative and Foreign Law Commons, Intellectual Property Commons,
International Trade Commons, and the Science and Technology Commons
This Article is brought to you for free and open access by FLASH: The Fordham Law Archive of Scholarship and History. It has been accepted for
inclusion in Faculty Scholarship by an authorized administrator of FLASH: The Fordham Law Archive of Scholarship and History. For more
information, please contact tmelnick@law.fordham.edu.
Recommended Citation
Mark Patterson, Contractual Expansion of the Scope of Patent Infringement through Field-of-Use Licensing , 49 Wm. & Mary L. Rev. 157
(2007-2008)
Available at: http://ir.lawnet.fordham.edu/faculty_scholarship/241
CONTRACTUAL EXPANSION OF THE SCOPE OF PATENT
INFRINGEMENT THROUGH FIELD-OF-USE LICENSING
MARK R. PATTERSON*
ABSTRACT
Patentees sometimes employ field-of-use licenses, under which they
grant the right to use their inventions, but only in specified ways.
Field-of-use licensing is often procompetitive, because the ability to
provide different licensing terms for different users can encourage
broader licensing of inventions. But in recent cases, the Court of
Appeals for the Federal Circuit and several district courts have
upheld field-of-use licenses that prohibited activities that would
otherwise have been permitted by patent law, such as the repair and
resale of patented products. By treating any violation of a license
agreement as patent infringement, and by upholding license
provisions that prohibited previously permitted activities, the courts
have allowed patentees to expand the scope of patent infringement
liability. This Article describes the dramatic expansion of patent law
that has resulted, and it advocates a test that would require a
patentee to show that the conduct it challenges would be infringe-
ment in the absence of a license before it can seek to make it
infringement by license. The Article also briefly compares these
effects in patent law to the analogous effects of shrink-wrap licenses
and the DMCA in copyright law, and it assesses the potential for
similar expansion of patent infringement liability in Europe.
* Professor of Law, Fordham University School of Law. This Article is an expanded
version of a chapter prepared for the forthcoming RESEARCH HANDBOOK ON COMPETITIONAND
INTELLECTUAL PROPERTY LAW, to be edited by Josef Drexl and published by Edward Elgar
Publishing Ltd. I would like to thank the participants in the preparatory conference for that
book at the Max Planck Institute in Munich in September 2006, and particularly Emanuela
Arezzo, for comments on the Article.
WILLIAM AND MARY LAW REVIEW
TABLE OF CONTENTS
INTRODUCTION .......................................
I. THE LEGAL FRAMEWORK FOR FIELD-OF-USE LICENSING ....
A. The Supreme Court
159
164
......... 164
B. The Federal Circuit .............................. 167
C. The IP Guidelines ................................ 172
D. Field-of-Use Licensing Rules in Europe .............. 172
II. THE U.S. APPROACH IN THE LOWER COURTS ............. 176
A. Recent Cases .................................... 177
1. Lexm ark ...................................... 177
2. Ottawa Plant Food ............................. 179
3. The Monsanto Cases ............................ 181
B. Shortcomings in the Courts' Contract and
Patent Analyses .................................. 185
1. Contract Analysis .............................. 185
2. Patent Analysis .....................
III. FIELD-OF-USE LICENSING AND THE SCOPE OF
PATENT INFRINGEMENT ...................
..... 190
A. The Scope of Infringement .........................
1. M aking and Repair .............................
2. Selling and Reselling ...........................
3. Self-Replicating Products ........................
B. Restrictions on Downstream Purchasers .............
IV. THE BENEFITS OF USE LICENSING ....................
A .Free R iding .....................................
1. "Free Riding" in Downstream Markets .............
2. Patents Related to the Use at Issue ................
B. Price Discrimination and Financing .................
1. Price Discrimination in Related Markets ...........
2. Price Discrimination Through Contract ............
3. Exceptional Cases Requiring Patent Protection ......
CONCLUSION ........................................
191
193
193
200
205
209
211
213
213
216
220
220
221
224
227
158 [Vol. 49:157
FIELD-OF-USE LICENSING
INTRODUCTION
Patentees have a variety of options for licensing their patented
inventions. One common technique is the field-of-use license, under
which the patentee grants the right to use the patented invention,
but only in a specified way. Field-of-use licensing is generally seen
as procompetitive, because the ability to provide different licensing
terms for different users can encourage broader licensing of inven-
tions.' For example, the Supreme Court has upheld a field-of-use
licensing arrangement under which several patentees licensed
third parties to manufacture audio amplifiers using their patented
technologies, but only for home use.2 This arrangement allowed the
patentees to reserve the right to manufacture for commercial use,
which was apparently more profitable, while still allowing the
technologies to be used broadly for home applications.' If licensing
had required the patentees to share the commercial business as
well, they might not have licensed the technologies for home use at
all.
But field-of-use licensing need not always be procompetitive. The
anticompetitive concerns can be especially great when the patentee
imposes restrictions on the ultimate purchasers of the patented
products rather than on manufacturing licensees.4 In recent U.S.
1. See, e.g., U.S. DEP'T OF JUSTICE & FED. TRADE COMM'N, ANTITRUST GUIDELINES FOR
THE LICENSING OF INTELLECTUAL PROPERTY (Apr. 6, 1995), available at http://www.usdoj.gov/
atr/public/guidelines/0558.htm [hereinafter IP GUIDELINES], ("Field-of-use, territorial, and
other limitations on intellectual property licenses may serve procompetitive ends by allowing
the licensor to exploit its property as efficiently and effectively as possible."); Commission
Notice, Guidelines on the Application of Article 81 of the EC Treaty to Technology Transfer
Agreements, 2004 O.J. (C 101/2) 182 [hereinafter TTBER Guidelines] ("Field of use
restrictions may have pro-competitive effects by encouraging the licensor to license his
technology for applications that fall outside his main area of focus."); Makan Delrahim, The
Long and Winding Road: Convergence in the Application of Antitrust to Intellectual Property,
13 GEO. MASON L. REV. 259, 264 (2005) (discussing the use of field-of-use licenses to price
discriminate among licensees and observing that "allowing the firm that developed the
[innovation] to price discriminate may increase social welfare by promoting the efficient
commercialization of the asset").
2. See Gen. Talking Pictures Corp. v. W. Elec. Co., 305 U.S. 124, 127 (1938).
3. See id. at 126.
4. Indeed, it has been argued that the Supreme Court decisions are best read only as
approving use restrictions on manufacturing licensees like that in General Talking Pictures.
See Richard H. Stern, The Unobserved Demise of the Exhaustion Doctrine in US Patent Law,
2007] 159
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cases, patentees have used field-of-use licensing to prevent pur-
chasers of patented products from repairing those products, and to
enforce distribution restraints.' In these contexts, the use restric-
tions might not have facilitated broader licensing. Instead, the
restrictions appear to have been employed to allow the patentees to
price discriminate or to control more fully activities in related
markets, neither of which is necessarily procompetitive.6
Furthermore, the effects of these recent field-of-use licensing
arrangements have not been carefully examined because the courts
have accorded them very deferential treatment.7 The Court of
Appeals for the Federal Circuit has established a test that depends
in theory on whether the restraint is "within the scope of the patent
claims,"' a criterion that could be useful in assessing the relation-
ship of use restrictions to the patentee's inventive contribution.
Subsequent decisions, however, have turned simply on the Federal
Circuit's view that any contractual condition on a license makes the
exhaustion doctrine inapplicable, 9 and on the court's unwillingness
to evaluate the effects of any license restrictions that are not per se
antitrust violations.10
Moreover, although these restrictions are contractual, their
effects are not simply matters of contract law. As a result of the
Federal Circuit's view that any violation of a patent license is patent
15 EuR. INTELL. PROP. REV. 460, 465 (1993) [hereinafter Stern, Unobserved Demise]. One
federal district court reached a similar conclusion, but was reversed by the Federal Circuit
in what has become the leading case on use licensing. See Mallinckrodt, Inc. v. Medipart, Inc.,
No. 89-C-4524, 1990 U.S. Dist. LEXIS 1974, at *10 (N.D. Ill. Feb. 16, 1990), rev'd in part,
vacated in part, 976 F.2d 700 (Fed. Cir. 1992). See infra Part IV.B.
5. See Ariz. Cartridge Remfrs. Ass'n, Inc. v. Lexmark Int'l, Inc., 290 F. Supp. 2d 1034,
1045 (N.D. Cal. 2003), affd, 421 F.3d 981 (9th Cir. 2005) (discussing prevention of repair);
Pioneer Hi-Bred Intl, Inc. v. Ottawa Plant Food, Inc., 283 F. Supp. 2d 1018, 1058 (D. Iowa
2003) (discussing distribution restraints). For further discussion of both cases, see infra notes
99-129 and accompanying text.
6. See infra Part II.A.
7. See id.
8. Mallinckrodt, 976 F.2d at 708.
9. Under the exhaustion doctrine, or first-sale doctrine, a patentee's rights in its
invention are exhausted upon the first sale of the invention. But the Federal Circuit has held
that the doctrine applies only to an unconditional sale, so that any restriction imposed by the
patentee-on the purchaser's field of use or otherwise-avoids application of the doctrine. See
infra text accompanying notes 46-60.
10. See infra text accompanying notes 63-71.
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infringement, contract law and patent law coincide here. 1 That is,
violation of the terms of a use license by a licensee or purchaser is
not only a breach of contract but also patent infringement. This
result is especially troubling because the Federal Circuit has
permitted patentees to restrict uses that the Supreme Court has
said are not patent infringement.12 As a result, the Federal Circuit's
rules allow patentees to use contract law to transform previously
permissible conduct into patent infringement." Indeed, the lower
courts have applied these rules in such a way as to give patentees
carte blanche to expand the scope of infringement. 4
This issue echoes two similar issues in copyright law. First,
several cases have considered contractual clauses in copyright
licenses that eliminate the fair use right to reverse engineer the
copyrighted software." Using contract in this way, to redefine copy-
right law, is similar to the application of use licensing to redefine
patent law. 6 Indeed, the copyright decisions are arguably less
troubling, in that the applicability of the fair use defense has not
been entirely clear in the cases that have allowed its elimination. 7
Second, a somewhat similar concern exists regarding the effect of
the Digital Millennium Copyright Act (DMCA)'5 on fair use.'9 The
11. Mallinckrodt, 976 F.2d at 707 n.6 ("IT]he remedy for breach of a binding license
provision is not exclusively in contract, for a license is simply a promise not to sue for what
would otherwise be patent infringement.").
12. See infra text accompanying notes 49-52 and Part III.A.
13. See discussion infra Parts I.B., II.A.
14. See infra Part II.A.
15. See, e.g., Davidson & Assocs. v. Jung, 422 F.3d 630, 632 (8th Cir. 2005); Bowers v.
Baystate Techs., Inc., 320 F.3d 1317, 1323 (Fed. Cir. 2003).
16. The contractual elimination of this fair use right has generally been decried by
commentators. See, e.g., Mark A. Lemley, Intellectual Property and Shrinkwrap Licenses, 68
S. CAL. L. REV. 1239, 1264 (1995); Michael J. Madison, Legal-Ware: Contract and Copyright
in the Digital Age, 67 FORDHAM L. REV. 1025, 1128-29 (1998); David A. Rice, Public Goods,
Private Contract and Public Policy: Federal Preemption of Software License Prohibitions
Against Reverse Engineering, 53 U. PiTt. L. REV. 543, 548-49 (1992).
17. Although most courts considering the issue have held that reverse engineering is a fair
use, they have generally focused on its use to make interoperable products. See, e.g., Sega
Enters. Ltd. v. Accolade, Inc., 977 F.2d 1510, 1514 (9th Cir. 1992); Atari Games Corp. v.
Nintendo of Am., Inc., 975 F.2d 832, 842-43 (Fed. Cir. 1992). Interoperability, however, was
not the central issue in either Bowers, 320 F.3d 1317, or Davidson, 422 F.3d 630. Cf. Alcatel
USA, Inc. v. DGI Techs., Inc., 166 F.3d 772, 793 (5th Cir. 1999) (holding that a contractual
tying restriction that prevented achievement of interoperability was copyright misuse).
18. 17 U.S.C. § 1201 (2006).
19. See, e.g., Dan L. Burk, Anticircumvention Misuse, 50 UCLA L. REV. 1095, 1105-06
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DMCA creates a cause of action against one who circumvents a
technological protection measure for a copyrighted work.2" No
general exception exists under the DMCA for circumvention for
fair use." Therefore, one who circumvents a technological
measure protecting a copyrighted work may be liable under the
DMCA, even if the use to which the copyrighted work would be put
is a fair use, and thus otherwise permissible under the Copyright
Act. This problem has arisen in a number of contexts 22 and is
presumably not the result Congress intended when it passed the
DMCA. 2' Nevertheless, one could argue that the result is at least
one created by statute. In contrast, the amendments of patent law
effected by use licensing have been created by the courts and
patentees with very little judicial, let alone legislative, analysis.24
Although the alteration of copyright law by contract and by the
DMCA has received much attention, the similar alteration of patent
law has been less noticed.25 The time is particularly opportune for
an assessment of field-of-use licenses because the use of such
licenses in the United States has increased, and the proper scope of
the licenses is a question likely to reach the Supreme Court soon.
Recently, the Federal Circuit upheld one such license 26 and the
(2003); Jacqueline D. Lipton, Solving the Digital Piracy Puzzle: Disaggregating Fair Use from
the DMCA'sAnti-Device Provisions, 19 HARV. J.L. & TECH. 111, 124-34 (2005).
20. 17 U.S.C. § 1201 (2006).
21. There is an exception for reverse engineering to achieve interoperability, 17 U.S.C. §
1201(f) (2006), but not for fair use more generally.
22. See ELEC. FRONTIER FOUND., UNINTENDED CONSEQUENCES: SEVEN YEARS UNDER THE
DMCA (2006), http://www.eff.org/IP/DMCA/DMCAunintended v4.pdf (documenting reported
cases in which anti-circumvention provisions of the DMCA have been invoked against
"consumers, scientists, and legitimate competitors.").
23. See R. Anthony Reese, Will Merging Access Controls and Rights Controls Undermine
the Structure of Anticircumvention Law?, 18 BERKELEY TECH. L.J. 619, 651 (2003).
24. See infra Part IIA.
25. Articles criticizing the Federal Circuit's approach in Mallinckrodt, Inc. v. Medipart,
Inc., 976 F.2d 700 (Fed. Cir. 1992), appeared in the wake of that decision. See James B.
Kobak, Jr., Contracting Around Exhaustion: Some Thoughts About the CAFC's Mallinckrodt
Decision, 75 J. PAT. & TRADEMARK OFF. SOC'Y 550, 562-64 (1993); Richard H. Stern, Post-Sale
Patent Restrictions After Mallinckrodt-An Idea in Search of Definition, 5 ALB. L.J. SCI. &
TECH. 1, 29-35 (1994) [hereinafter Stern, Post-Sale]; Stern, Unobserved Demise, supra note
4, at 465. As discussed here, however, the pace and variety of patentees' exploitation of the
opportunities offered by Mallinckrodt have recently increased. See Peter Carstensen, Post-
Sale Restraints Via Patent Licensing: A "Seedcentric" Perspective, 16 FORDHAM INTELL. PROP.
MEDIA & ENT. L.J. 1053, 1053 (2006).
26. Monsanto Co. v. McFarling, 363 F.3d 1336, 1342-43 (Fed. Cir. 2004).
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licensee petitioned for certiorari; the Supreme Court asked for the
views of the Solicitor General before denying the application,
indicating that the Court has taken an interest in the issue.27
This Article argues that patent law limitations should be restored
to field-of-use licensing. More specifically, the courts should
recognize that the scope of infringement liability is defined in the
first instance by patent law, not by contract. Within the limits of
infringement liability, contracts can permit or deny users the right
to make particular uses of the invention. Outside the scope of
infringement liability as it is defined by patent law, however,
patentees cannot create new forms of infringement. Hence, this
Article argues that in any analysis of the violation of a license the
first step-a step that has been neglected by some lower courts
-should be to ask whether the challenged conduct is within the
scope of patent infringement as defined by patent law. Contrary to
some recent decisions, only if the answer to that question is yes does
it become relevant whether the conduct was licensed.
The Article proceeds in the next Part by outlining the legal
background for field-of-use licensing; this discussion focuses on the
law in the United States, but it also describes how the law in
Europe is critically different in this area. Part II then describes
several recent cases from the lower U.S. courts and examines
shortcomings in the analyses of those courts, both with respect to
patent law and contract law, again drawing comparisons to the law
in Europe. Part III describes the effect of unbridled field-of-use
licensing, which is to allow patentees to define by contract the
nature of patent infringement without regard to previous limita-
tions on infringement. Finally, Part IV describes alternative means
that patentees could use to achieve the procompetitive purposes
served by field-of-use licensing.
27. The Solicitor General filed a brief arguing that the petition for certiorari should be
denied. Brief for the United States as Amicus Curiae Supporting Respondents, McFarling v.
Monsanto Co., 545 U.S. 1139 (2005) (No. 04-31).
2007]
WILLIAM AND MARY LAW REVIEW
I. THE LEGAL FRAMEWORK FOR FIELD-OF-USE LICENSING
The legal framework for field-of-use licensing is somewhat
confused. The Supreme Court approved use licensing in one case,2"
but both that case and others suggest limitations on use licensing
that the Federal Circuit has eliminated. The first two sections below
discuss the use licensing cases from both courts, but because the law
is uncertain, it is worth considering also how field-of-use licenses
are treated in other jurisdictions. Therefore, the final section below
discusses the treatment of use licensing in Europe, where the
European Commission has maintained some important distinctions
that the Federal Circuit has abandoned.
A. The Supreme Court
The Supreme Court has said that a patentee "may grant a license
'upon any condition the performance of which is reasonably within
the reward which the patentee by the grant of the patent is entitled
to secure."'29 This statement, from General Talking Pictures Corp.
v. Western Electric Co., a 1938 case that is still the Court's leading
case on use licensing, appears to contemplate review of the economic
justification for a license restriction by focusing on whether the
restriction provides the patentee with rewards beyond those to
which the patent entitles it. The case involved a restriction in an
agreement that permitted a licensee to manufacture goods using the
patented technology for a limited market, as described above. 30
A case like General Talking Pictures, in which the use restriction
is imposed on a manufacturing licensee, differs from recent use-
licensing cases, in which the restrictions have been imposed on the
ultimate purchasers of the patented product.31 Of course, a patentee
is free to restrict its own use of its patent in whatever way it
chooses, and there seems no reason why a patentee's decision to
license others to manufacture the patented product, rather than to
28. See supra notes 2-3 and accompanying text; see also Gen. Talking Pictures Corp. v. W.
Elec. Co., 305 U.S. 124, 126-27 (1938).
29. Gen. Talking Pictures, 305 U.S. at 127 (quoting United States v. Gen. Elec. Co., 272
U.S. 476, 489 (1926)).
30. See supra notes 2-3 and accompanying text.
31. See discussion infra Part II.A.
164 [Vol. 49:157
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manufacture the product itself, should eliminate that freedom. That
is, manufacturing licensees in effect stand in the shoes of the
patentee, and imposing use restrictions on them can reasonably be
treated as economically equivalent to individual decisions by the
patentee itself, as the Supreme Court has indicated. 2
Restrictions on the purchasers of patented goods, however, cannot
be viewed as equivalent to restrictions on the patentee itself.
Furthermore, the Supreme Court has never upheld the use of a
patent infringement suit to enforce license restrictions on the
ultimate purchasers of patented products. Although the Court has
also never said that such restrictions are unenforceable through
patent law, it has described the exhaustion principle in a way that
suggests this conclusion, holding that when a patentee "sells a
machine or instrument whose sole value is in its use, he receives the
consideration for its use and he parts with the right to restrict that
use."
33
Such exhaustion of the patentee's patent rights does not necessar-
ily exhaust its right to restrict use of its products through other
means, though. More particularly, the Court has indicated that any
restrictions on the ultimate users of patented products are subjects
of contract law, not patent law: 'The extent to which the use of the
patented machine may validly be restricted to specific supplies or
otherwise by special contract between the owner of a patent and the
purchaser or licensee is a question outside the patent law and with
it we are not here concerned." 4 Additionally, restrictions that are
purely contractual would not receive any of the protection from
antitrust scrutiny that might be accorded a restriction under patent
law. For example, in United States v. Univis Lens Co.,3  in which the
patentee "licensed" both its wholesalers and retailers on terms that
set sales prices, the Court said that "[t]he added stipulation by the
32. See Bement v. Nat'l Harrow Co., 186 U.S. 70, 93 (1902) ('The owner of a patented
article can, of course, charge such price as he may choose, and the owner of a patent may
assign it or sell the right to manufacture and sell the article patented upon the condition that
the assignee shall charge a certain amount for such article.").
33. Adams v. Burke, 84 U.S. (17 Wall.) 453, 456 (1873).
34. Motion Picture Patents Co. v. Universal Film Mfg. Co., 243 U.S. 502, 509 (1917) (citing
Keeler v. Standard Folding Bed, 157 U.S. 659 (1895)); see also Keeler, 157 U.S. at 666 ("It is,
however, obvious that such a question would arise as a question of contract, and not as one
under the inherent meaning and effect of the patent laws.").
35. 316 U.S. 241 (1942).
20071 165
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patentee fixing resale prices derives no support from the patent and
must stand on the same footing under the Sherman Act as like
stipulations with respect to unpatented commodities." 6
Moreover, the Court has taken care to ensure that patentees do
not avoid the limits discussed above by merely formal means. For
example, in Victor Talking Machine,37 the patentee sought to
characterize the purchasers of its products as licensees, but the
Court rejected that approach:
If we look through the words and forms, with which the
plaintiff has most elaborately enveloped its purpose, to the
substance and realities of the transaction contemplated, we shall
discover several notable and significant features. First, while as
if looking to the future, the notice, in terms, imposes various
restrictions as to title and as to the "use" of the machines by
plaintiffs agents, wholesale and retail, and by the "unlicensed
members of the public," for itself, the plaintiff makes sure, that
the future shall have no risks, for it requires that all that it asks
or expects at any time to receive for each machine must be paid
in full before it parts with the possession of it.8
The Court indicated that the traditional distinction between
property and non-property rights was determinative:
Courts would be perversely blind if they failed to look through
such an attempt as this "License Notice" thus plainly is to sell
property for a full price, and yet to place restraints upon its
further alienation, such as have been hateful to the law from
Lord Coke's day to ours, because obnoxious to the public
interest.39
In this fashion, the Court has traditionally resisted attempts to use
contract to expand the scope of patent law.
36. Id. at 251 (citing Ethyl Gasoline Corp. v. United States, 309 U.S. 436 (1940)).
37. Straus v. Victor Talking Mach. Co., 243 U.S. 490 (1917).
38. Id. at 498.
39. Id. at 500-01.
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B. The Federal Circuit
The Court of Appeals for the Federal Circuit, which is the
primary appellate court for patent issues in the United States, has
replaced the Supreme Court's substantive approach with a formal
one. The source of the formal approach is Mallinckrodt, Inc. v.
Medipart, Inc.,40 in which the Federal Circuit reviewed the validity
of a restriction that took the form of a "single use only" inscription
on the patented product. The patent covered a "nebulizer" for the
delivery of radioactive or medicinal substances in aerosol form to
the lungs of medical patients.4' The alleged infringer accepted the
used products from hospitals, sterilized them with high doses of
radiation, repackaged them with new (unpatented) components, and
resold them to the hospitals.42
The district court's analysis was consistent with the Supreme
Court's approach4" and focused on the fact that the restriction had
been imposed on a purchaser of the patented product, not a
manufacturing licensee.44 On appeal, the Federal Circuit said that
the district court "held that no restriction whatsoever could be
imposed under the patent law, whether or not the restriction was
enforceable under some other law, and whether or not this was a
first sale to a purchaser with notice."45 The district court's holding
was actually limited to restrictions on the ultimate purchasers of
the patented products and was consistent with Supreme Court
holdings. But by (mis)representing the district court's holding more
broadly, the Federal Circuit was able to conclude that it was
inconsistent with precedent and to substitute its own approach.
The first step in the Federal Circuit's own analysis was to
determine that the exhaustion doctrine was inapplicable. To do so,
the court relied on the purported "condition" on the sale of the
product created by the "single use only" notice.46 Although the court
explicitly declined to decide whether the notice was sufficient to
40. 976 F.2d 700 (Fed. Cir. 1992).
41. Id. at 701-02.
42. Id. at 702.
43. See supra Part I.A.
44. See Mallinckrodt, Inc. v. Medipart, Inc., No. 89-C-4524, 1990 U.S. Dist. LEXIS 1974,
at *6 (N.D. Ill. Feb. 16, 1990), rev'd in part, vacated in part, 976 F.2d 700 (Fed. Cir. 1992).
45. Mallinckrodt, 976 F.2d at 701.
46. Id. at 703.
2007] 167
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create a contract,47 it rejected the district court's reliance on the
exhaustion doctrine as applicable only to unconditional sales.48 In
this way, the Federal Circuit established a new rule, based on its
interpretation of the Supreme Court's cases:49 'This exhaustion
doctrine ... does not apply to an expressly conditional sale or
license. 5 °
This broad statement, however, is not supported by Supreme
Court decisions. Although the Court has sometimes observed that
sales were made "without any conditions" in rejecting infringement
suits against purchasers,51 it has never suggested that simply
imposing conditions of any kind would allow infringement suits
against purchasers. On the contrary, the Court has relied on the
exhaustion doctrine in many cases despite conditions attached to
the original sale. 52 It is true that in the only cases in which the
Court has considered violations by purchasers of patentee-imposed
conditions, those conditions were per se antitrust violations. 3 In
several cases, however, the Court has rejected infringement suits
against parties that bought patented goods in the exclusive territory
of one licensee and resold them in the territory of another.5 4 The
challenged conduct in those cases certainly subverted the goals of
the patentees' restrictions, but the Court held that the patentees'
rights were exhausted by the initial sales, which were in compliance
47. See id. at 709.
48. Id. at 708.
49. There was no clear precedent for this rule. Mallinckrodt simply said that "[v]iewing
the entire group of these early [Supreme Court] cases, it appears that the Court simply
applied, to a variety of factual situations, the rule of contract law that sale may be
conditioned." Id. at 708 (footnote omitted). The critical point ignored by this statement is the
distinction between contract law and property law. That a condition may be imposed as a
matter of contract does not necessarily mean that it may be enforced through the property
protections of patent law. Cf. F.2d at 707 n.6 ("Mhe remedy for breach of a binding license
provision is not exclusively in contract, for a license is simply a promise not to sue for what
would otherwise be patent infringement." (citations omitted)).
50. B. Braun Med. Inc. v. Abbott Labs., 124 F.3d 1419, 1426 (Fed. Cir. 1997).
51. See Keeler v. Standard Folding Bed Co., 157 U.S. 659, 663 (1895) (quoting Mitchell
v. Hawley, 83 U.S. (16 Wall.) 544, 546-47 (1873)).
52. See infra notes 54-55.
53. See, e.g., Motion Picture Patents Co. v. Universal Film Mfg. Co., 243 U.S. 502 (1917)
(addressing tying); Bauer & Cie v. O'Donnell, 229 U.S. 1, 16-18 (1913) (addressing resale price
maintenance).
54. See, e.g., Keeler, 157 U.S. 659; Hobbie v. Jennison, 149 U.S. 355 (1893); Adams v.
Burke, 84 U.S. (17 Wall) 453 (1873).
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with the restrictions because they were made in the assigned
territories. 55
General Talking Pictures was different. In that case, the Court
permitted an infringement suit against a purchaser, but the Court
relied on the fact that the original sale was in violation of the license
restriction. The Court emphasized that the licensee had manufac-
tured the products outside the scope of its license, which was limited
to a particular field of use.5" The purchaser was liable for infringe-
ment, the Court made clear, not because it had used the products
outside the scope of a license, but because, knowing that the
manufacturing licensee had exceeded the scope of its license, the
purchaser was "in no better position than if it had manufactured the
amplifiers itself without a license."57 Mallinckrodt was different
because the original sale of the nebulizer did not violate the "single
use only" restriction, so it was a valid first sale.58 Furthermore,
nothing in the Supreme Court's decisions indicates that the
presence of a purported restriction that would apply only to the
ultimate purchaser would prevent the application of the exhaustion
doctrine.59
Nevertheless, given the Federal Circuit's holding in Mallinckrodt
that the patentee's restriction avoided the exhaustion doctrine, the
next step was to determine whether the restriction was permissible
as a matter of patent law. Here, the Federal Circuit set out a test
that appeared to be consistent with the Supreme Court's: 'The
appropriate criterion is whether Mallinckrodt's restriction is
reasonably within the patent grant, or whether the patentee has
ventured beyond the patent grant and into behavior having an
anticompetitive effect not justifiable under the rule of reason."60 The
first part of this test is consistent with the Supreme Court's
approach if asking whether a restriction "is reasonably within the
patent grant" is the same as asking whether it "is reasonably within
the reward which the patentee by the grant of the patent is entitled
55. See Keeler, 157 U.S. at 661; Hobbie, 149 U.S. at 362-63; Adams, 84 U.S. at 456-57.
56. See Gen. Talking Pictures Corp. v. W. Elec. Co., 305 U.S. 124, 126 (1938).
57. Id. at 127.
58. See Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 703 (Fed. Cir. 1992).
59. See supra notes 52-58 and accompanying text.
60. Mallinckrodt, 976 F.2d at 708.
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to secure." 1 Further, by making the restriction subject to antitrust
law, the second part of the test would effectively treat it as any
other contractual restriction, as the Supreme Court directed.
In fact, though, Mallinckrodt allowed a very broad scope for field-
of-use restrictions. Whereas the Supreme Court's test appeared to
focus on the economic effects of a restriction, the Federal Circuit in
Mallinckrodt interpreted its "within the patent grant" test as a more
technical one, asking whether the restriction "relates to subject
matter within the scope of the patent claims."6 But the court did not
explain what is required for a restriction to "relate" to patent claims.
At its broadest, as the requirement has in fact come to be inter-
preted, it could simply mean that the defendant's activity in some
way involves the patented invention. Such an interpretation
effectively removes any limitations on field-of-use licensing.
Indeed, subsequent to Mallinckrodt, the Federal Circuit has
granted patentees wide latitude over field-of-use licensing. The
first step in this expansion of permissible field-of-use licensing
came in B. Braun Medical Inc. v. Abbott Laboratories,3 which recast
the question of whether the use restriction is within the scope of
the patent claims into a question of whether "the patentee has
'impermissibly broadened the "physical or temporal scope" of the
patent grant with anticompetitive effect."'64 Braun offered only tying
and enforcement of the patent beyond its term as examples of such
impermissible broadening and said that "field of use restrictions ...
are generally upheld."65
More recently, the Federal Circuit appears, though in passing and
perhaps in dictum, to have eliminated all doubt about the status of
field-of-use licenses:
Under the patent laws, a patentee has the right to exclude
others from making, using, or selling a patented invention.
Conduct falling within the scope of protection includes, inter
alia, limited use licensing, and charging of royalties. Field of use
61. See supra note 29 and accompanying text.
62. Mallinckrodt, 976 F.2d at 708.
63. 124 F.3d 1419 (Fed. Cir. 1997).
64. Id. at 1426 (quoting Windsurfing Int'l, Inc. v. AMF, Inc., 782 F.2d 995, 1001 (Fed. Cir.
1986) (quoting Blonder-Tongue Labs., Inc. v. Univ. of Ill. Found., 402 U.S. 313, 343 (1971),
and citing Mallinckrodt, 976 F.2d at 704)).
65. Id.
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licensing restrictions, i.e., permitting the use of inventions in one
field and excluding it in others, are also within the scope of the
patent grant.6
In making these statements, the court cited not only Mallinckrodt
but also General Talking Pictures, which, as described above,6 v was
a considerably more narrow decision.
The extent to which Federal Circuit law in this area has deviated
from the Supreme Court's is also illustrated by its treatment of
the right of the purchaser of a patented product to repair the
product. The Supreme Court has held that purchasers of pat-
ented goods have the right to repair those goods, though not the
right to reconstruct them.68 The Federal Circuit, however, said in
Mallinckrodt that if the "single use only" restriction there was valid
(presumably under its "within the patent grant" test 69), "any reuse
is unlicensed and an infringement, and there is no need to choose
between repair and reconstruction."" The implication of this
approach was to take the right of repair, which appeared to be a
limitation on a patentee's rights, and give the patentee contractual
control over it.
The result was especially odd because the Supreme Court, in
describing the right of repair, had said that when distinguishing
between repair and reconstruction, its decisions had "steadfastly
refused to extend the patent monopoly beyond the terms of the
grant."'" That is, the Supreme Court viewed the repair right as a
limit on the patent grant. In contrast, the Federal Circuit, despite
stating that its test turned on whether a restriction was "within the
patent grant," allowed patentees to eliminate the repair right by
contract.7 2 In this respect, and as illustrated more generally in this
Section, Federal Circuit precedent stands in contrast to that
established by the Supreme Court.
66. Monsanto Co. v. Scruggs, 459 F.3d 1328, 1338 (Fed. Cir. 2006) (citations omitted).
67. See supra notes 56-59 and accompanying text.
68. See Aro Mfg. Co. v. Convertible Top Replacement Co., 365 U.S. 336, 346 (1961).
69. See Mallinckrodt, 976 F.2d at 708.
70. Id. at 709.
71. Aro Mfg. Co., 365 U.S. at 342.
72. See Maflinckrodt, 976 F.2d at 708.
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C. The IP Guidelines
Although these court decisions establish current U.S. law, the
federal antitrust agencies have expressed their own views on field-
of-use licenses. The agencies' Antitrust Guidelines for the Licensing
of Intellectual Property7 3 state that field-of-use licenses "may serve
procompetitive ends by allowing the licensor to exploit its property
as efficiently and effectively as possible."74 Interestingly, this state-
ment is followed by an example that illustrates use licensing with
restrictions on ultimate purchasers v.7  The example restrictions,
however, truly limit the field of use to settings such as hospitals or
group medical practices; they do not limit the manner in which the
purchasers may use the intellectual property within that field, as
the "single use only" restriction in Mallinckrodt did. That is, the
restrictions approved in the example are akin to those in General
Talking Pictures, in that they serve to partition the market among
purchasers, rather than to the restrictions in Mallinckrodt, which
partition the market within individual purchasers.
D. Field-of- Use Licensing Rules in Europe
In contrast to the United States, field-of-use licensing in Europe
is addressed by regulation. Specifically, use licensing can be exempt
under the European Commission's Technology Transfer Block
Exemption Regulation (TTBER).v6 For most of the use-licensing
arrangements in recent U.S. cases, however, the TTBER would be
73. IP GUIDELINES, supra note 1.
74. Id. at 5.
75. Id. at 6.
76. Commission Regulation (EC) No. 772/2004 on the Application of Article 81(3) of the
Treaty to Categories of Technology Transfer Agreements, 2004 O.J. (L 123/11) [hereinafter
TTBER].
The TTBER generally exempts licensing restrictions between firms whose market shares
do not exceed specified thresholds. If the parties are noncompetitors, the block exemption
applies so long as the share of neither party exceeds 30 percent. Id. at art. 3(2). If they are
competitors, the block exemption applies so long as the parties' combined share does not
exceed 20 percent. Id. at art. 3(1). The exemption does not apply, however, to restrictions that
are in "hardcore" or "excluded" categories, but field-of-use licensing generally does not fall into
those categories. The TTBER specifically excludes nonreciprocal use licensing between
competitors from the hardcore category, and use licensing does not fall into any of the
hardcore categories for licenses between noncompetitors. Id. at art. 4(1)(c)(i)-(ii).
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inapplicable. For example, consider Mallinckrodt, which involved a
license to a user of the patented product, not to a producer of it. 77
Because the TTBER applies only to "technology transfer agreements
entered into between two undertakings permitting the production
of contract products,"78 the license in Mallinckrodt would not qualify
as a technology transfer agreement under the TTBER.
The significance of this point lies in what it says about a use
restriction like that in Mallinckrodt. It is telling that the TTBER
does not view a restriction on the sale of a completed product as
involving a transfer of the patentee's technology, which suggests
that the Mallinckrodt patent was only peripheral to the restriction.
Indeed, the transfer of a completed product does not necessarily
implicate patented technology in the same way as the manufacture
of the product does. The manufacturer of the patented product cer-
tainly pays the patentee for the technology and reaps the benefit of
selling a product that incorporates that technology. Whether a
downstream restriction on purchasers also implicates the technology
itself, however, or does so in a way that the purchasers have not
already paid for, is exactly the inquiry contemplated by the U.S.
Supreme Court's requirement that a condition imposed by the
patentee be "reasonably within the reward which the patentee by
the grant of the patent is entitled to secure." 9 The Federal Circuit's
approach avoids this inquiry, which is discussed further below,8" but
by not automatically exempting downstream restrictions, the
TTBER insists upon it.
Another way to illustrate the implications of the TTBER's focus
on the production of the patented product is to focus on the recondi-
tioning of the product performed by the defendant in Mallinckrodt
and on patent law's repair doctrine. Perhaps it could be argued that
because the purchasers in Mallinckrodt arranged for the recondi-
77. See supra Part I.B.
78. TTBER, supra note 76, at art. 2 (emphasis added); see also TTBER Guidelines, supra
note 1, 41 ("It follows from Article 2 that for licence agreements to be covered by the TTBER
they must concern 'the production of contract products,' that is, products incorporating or
produced with the licensed technology. In other words, to be covered by the TTBER the licence
must permit the licensee to exploit the licensed technology for production of goods or services
(see recital 7 of the TTBER).").
79. Gen. Talking Pictures Corp. v. W. Elec. Co., 305 U.S. 124, 127 (1938) (citation
omitted).
80. See infra Part W.A.
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tioning of the nebulizer, the 'license" of the nebulizer permitted the
"production"-that is, the reconditioning-of the product, as the
TTBER requires. The "license" in Mallinckrodt, however, actually
forbade reconditioning, so it seems difficult to view the Mallinckrodt
license, or the other similar licenses discussed below, as permitting
production of the patented product.8 That is, the sale in
Mallinckrodt permitted the reconditioning in the sense that it made
the product available, but the license agreement itself did not
permit reconditioning, or production, of the patented product.
Whether a patented product may permissibly be reconditioned is
the exact question addressed by the repair doctrine, which is
discussed further below.82 By denying an antitrust exemption to no-
repair restrictions like those in Mallinckrodt, the TTBER requires
a patentee to argue that a reconditioner is reconstructing the
patented product and thus infringing.8 Again, the Federal Circuit's
approach short-circuits this inquiry by allowing the patentee to
simply argue that the reconditioner (or the purchaser"4) is violating
the contractual restriction requiring only a single use.
These points are reinforced by the definition of a field-of-use li-
cense provided in the TTBER and in its accompanying Guidelines.8 5
That definition is critical in the TTBER because if a particular
restriction is not in fact a field-of-use license, but some other sort of
restriction, the TTBER might not exempt it. 6 Analogously, the
characterization of these restrictions as use restrictions leads to
deferential treatment of them in the United States, despite the fact
that the courts have not articulated a definition of a "use" restric-
tion.87 The TTBER's reference to field-of-use licensing limits the
exemption to "the obligation on the licensee(s) to produce with the
licensed technology only within one or more technical fields of use
81. The Monsanto cases discussed below differ in this respect, however. See infra Parts
III.A.3, IV.B.3.
82. See infra Part III.A. 1.
83. See TTBER Guidelines, supra note 1, 182.
84. Although the defendant in Mallinckrodt was the reconditioner, it is actually the
purchaser that uses the product a second time and thus arguably violates the "single use only"
restriction.
85. TTBER Guidelines, supra note 1, 179.
86. See supra note 76.
87. See infra note 90.
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or one or more product markets.""8 The Guidelines further state
that "the field of use must be defined objectively by reference to
identified and meaningful technical characteristics of the licensed
product." 9
This approach appears to contrast with the Federal Circuit's
approach in the United States, where that court appears to view any
restriction on use as a field-of-use restriction, regardless of whether
it is related to the patented technology or its "technical characteris-
tics."9 ° If the use restrictions in Mallinckrodt and recent cases
instead were viewed as other sorts of restrictions-such as customer
restrictions, territorial restrictions, or, more generally, typical
nonprice vertical restraints 91-the appropriate treatment of the
88. TTBER, supra note 76, at art. 4(1)(c)(i). The "product market" possibility recalls the
use restriction discussed in the U.S. IP Guidelines. See supra notes 74-76 and accompanying
text.
89. TTBER Guidelines, supra note 1, 180.
90. The Federal Circuit has not really provided a definition of a field-of-use restriction,
but after reviewing the Supreme Court cases, it said that "[v]iewing the entire group of these
early cases, it appears that the Court simply applied, to a variety of factual situations, the
rule of contract law that sale may be conditioned." Mallinckrodt, Inc. v. Medipart, Inc., 976
F.2d 700, 708 (Fed. Cir. 1992); see also B. Braun Med., Inc. v. Abbott Labs., 124 F.3d 1419,
1426 (Fed. Cir. 1997) ("[E]xpress conditions accompanying the sale or license of a patented
product are generally upheld."). The court thus appears to include a nearly unlimited range
of restrictions within the category of use restrictions. On the other hand, one might view its
reference to restrictions "reasonably within the patent grant" as a more narrow definition of
use restrictions. Under that interpretation, use restrictions, or restrictions "reasonably within
the patent grant," would be per se legal, see Mallinckrodt, 976 F.2d at 708, and other
restrictions would be judged under the rule of reason. Under either interpretation, the Federal
Circuit's scrutiny is less searching than that contemplated by the TTBER.
91. It is worth pointing out here that in Europe the restriction in Mallinckrodt and similar
restrictions probably would not be viewed as typical nonprice distribution restraints. The EC's
vertical agreement regulation applies to agreements between undertakings in which each
operates "at a different level of the production or distribution chain." Commission Regulation
(EC) No. 2790/1999 on the Application of Article 81(3) of the Treaty to Categories of Vertical
Agreements and Concerted Practices, 1999 O.J. (L 336/21) art. 2(1) [hereinafter Vertical
Agreement Regulation]. The purchasers of the patented products in a case like Mallinckrodt
are not really in the distribution chain because they use the finished product in their own
operations, rather than distributing it to downstream purchasers.
In this respect, it is possible to draw by analogy on the EC's motor vehicle block exemption,
in which the regulation states that "independent repairer' means a provider of repair and
maintenance services for motor vehicles not operating within the distribution system set up
by the supplier." Commission Regulation (EC) No. 1400/2002, On the Application of Article
81(3) of the Treaty to Categories of Vertical Agreements and Concerted Practices in the Motor
Vehicle Sector, 2002 O.J. (L 203/30) art. 1(m). This language indicates that independent
aftermarket reconditioners of patented products, like the defendant in Mallinckrodt, would
not be viewed by the Commission as within the distribution chain. Again, this suggests that
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restrictions would be less obviously related to the patentee's
intellectual property rights. Consequently, the restrictions could
then be seen to be merely contractual and subject to limitations
such as antitrust law, as the Supreme Court has directed.92
In sum, the European approach in the TTBER is considerably
more demanding than the Federal Circuit's approach. More to the
point, perhaps, it seems similar to the Supreme Court's approach.
Like the Supreme Court, but unlike the Federal Circuit, the TTBER
confines the application of field-of-use licenses to manufacturing
licensees. Moreover, the TTBER requires that the field of use be
defined by the "technical characteristics of the licensed product,"93
an approach that is in accord with the language of the Federal
Circuit's test but not with its application.
II. THE U.S. APPROACH IN THE LOWER COURTS
The actual result in Mallinckrodt was not as troubling as is the
path on which it set other U.S. courts. Mallinckrodt merely returned
the case to the district court for reconsideration of the "single use
only" restriction, so it is not clear that even under the Federal
Circuit's test the restriction would have been permissible. 4 But as
Richard Stern has said, interpreted broadly, "Mallinckrodt would
permit patentees to accomplish many things that previously were
infeasible."95 In fact, this prediction has been borne out as the courts
have relied on Mallinckrodt to reach results that appear to be
anticompetitive." Just as importantly, the courts in these cases
have failed to examine carefully either the patent law or contract
law issues that they present.
restrictions like those in Mallinckrodt should not receive the deferential treatment accorded
to distribution restraints, but should be evaluated under the repair doctrine of patent law.
92. See, e.g., Bus. Elecs. Corp. v. Sharp Elecs. Corp., 485 U.S. 717 (1988); Cont'l T.V., Inc.
v. GTE Sylvania Inc., 433 U.S. 36 (1977).
93. TTBER Guidelines, supra note 1, 180.
94. The district court might have determined that the Federal Circuit had not preempted
the possibility that a restriction on the right to recondition the product was outside the scope
of the patent. The parties settled the case, though, so the district court issued no decision on
remand.
95. Stern, Post-Sale, supra note 25, at 8.
96. See infra Part IIA.
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A. Recent Cases
1. Lexmark
The lack of scrutiny given the post-Mallinckrodt cases by the
courts was illustrated in Arizona Cartridge Remanufacturers
Association v. Lexmark International, Inc.9 7 Although presented
indirectly,98 the issue in Lexmark was whether Lexmark could
enforce a restriction on purchasers of its laser printer toner
cartridges that required the buyers to return their used cartridges
to Lexmark and prohibited refilling them.99 Lexmark also offered
cartridges for which refilling was permissible, but at a higher
price.1 °° In effect, then, the question was whether Lexmark could
enforce the price difference, which it referred to as a "Prebate"
program, through patent law. 1'
The district court applied an analysis similar to that of the
Federal Circuit in Mallinckrodt. First, the court indicated that the
exhaustion doctrine does not apply where a sale is conditioned.1 2
Next, it held that the Lexmark sale was in fact conditioned because
the buyer of the cartridge was on notice of the restriction and in
exchange for it paid a lower price.' 3 Whether notice of the sort
provided is sufficient to create a contract is controversial, as
discussed below,0 4 but the court was not troubled by the issue. By
relying on the notice, the Lexmark court followed the approach that
was adopted in a footnote in Mallinckrodt; however, Mallinckrodt
did not provide a correct exposition of contract law.'0 5
On the patent issues, the Lexmark district court concluded that
the use restriction was enforceable, though here the reasoning was
opaque:
97. 290 F. Supp. 2d 1034 (N.D. Cal. 2003), aff'd, 421 F.3d 981 (9th Cir. 2005).
98. See infra note 111 and accompanying text.
99. Lexmark, 290 F. Supp. 2d at 1042.
100. Id. at 1037.
101. Id.
102. Id. at 1043.
103. Id. at 1044.
104. See infra Part II.B.1.
105. See id.
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In short, the circumstances of the sale indicate: (1) purchasers,
including end-users, are on notice of the single-use condition; (2)
purchasers have an opportunity to reject the condition; and (3)
the Prebate is offered at a special price that reflects an exchange
for a single-use condition. Based on these circumstances, the
Court concludes that Lexmark has not exhausted its rights. The
Prebate is a conditional sale and the single-use condition is
enforceable. "°
Again, the court appeared to be relying on its conclusion that the
use restriction was part of a valid contract. 107 That a restriction is
binding under contract law, however, does not establish that it is
permissible as a matter of patent law. Consequently, the court's
approach neglected entirely the "within the patent grant" inquiry
established by Mallinckrodt.'0
Most tellingly, the district court in Lexmark did not provide any
discussion of the patents at issue. It is difficult to see how it is
possible to determine whether a restriction "relates to subject
matter within the scope of the patent claims"'0 9 without even
referring to those claims. In part, the court's approach might have
neglected the patents because the case was brought by the plaintiff
on a false advertising theory, under which it argued that Lexmark's
imposition of the no-refilling condition was misleading because
patent law prohibited it. "0 Additionally, the plaintiff apparently did
not pursue the patent issue vigorously and did not even raise it on
appeal."' But the patent issues were essential to the claim."2
106. Lexmark, 290 F. Supp. 2d at 1045.
107. The court also showed elsewhere in its opinion that it treated the two inquiries as
identical: "To determine whether Lexmark's Prebate imposes an unenforceable post-sale
condition, the Court must determine whether the circumstances of the Prebate sale indicate
that Lexmark exhausted its patent rights." Id. at 1042.
108. Alternatively, the court implicitly treated the issue as one of repair that was decided
by Mallinckrodt: 'Thus, where the purchaser of an unconditional sale has every right to repair
the device, the purchaser of a conditional sale does not." Id. at 1043 (citing Mallinckrodt, Inc.
v. Medipart, Inc., 976 F.2d 700, 709 (Fed. Cir. 1992) ("[Elven repair of an unlicensed device
[a conditionally sold device] constitutes infringement.")).
109. Maflinckrodt, 976 F. Supp. 2d at 708.
110. Lexmark, 290 F. Supp. 2d at 1039.
111. See Arizona Cartridge Remfrs. Ass'n, Inc. v. Lexmark Intl, Inc., 421 F.3d 981,987 (9th
Cir. 2005).
112. See Lexmark, 290 F. Supp. 2d at 1037 ("This may not be a patent case, but to dete-
rmine whether or not Lexmark has engaged in deceptive and unfair business practices the
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Consequently, the court's failure to address the enforceability of the
restriction as a separate issue is perplexing.
2. Ottawa Plant Food
Another recent case presents an even more surprising application
of a use restriction. In Pioneer Hi-Bred International, Inc. v. Ottawa
Plant Food, Inc.,"' the court upheld a "no resale" policy, despite the
fact that such a policy is an explicit contractual elimination of the
exhaustion doctrine. In fact, subsequent to the events at issue in the
case, the patentee, Pioneer, actually imposed an explicit prohibition
on resale. The restriction before the court, however, stated that
purchasers' uses of the patented product, seed corn, were limited
"only to produce forage or grain for feeding or processing."1 4 Pioneer
argued that under this restriction resales were impermissible,
contending that since a purchaser who resold the corn was not using
it to produce forage or grain, the resale was outside the scope of the
license and was therefore infringement.'
Despite this patent infringement claim, the case actually
concerned distribution restraints. Pioneer used a system of autho-
rized dealers, and Ottawa was not a part of Pioneer's distribution
system.116 Instead, Ottawa obtained corn from an authorized dealer
of Pioneer's products and resold it to farmers in a different geo-
graphical territory."7 In the usual nonpatent case, Pioneer could
have sued the authorized dealer who sold to Ottawa if its contract
with that dealer did not permit the sales. It is unlikely, however,
that it could have sued Ottawa itself."' Therefore, by use of the no-
resale restrictions, Pioneer sought to use patent law to enforce a
distribution policy that would have been difficult to enforce through
contract.
Court must analyze this case under the rubric of patent law.").
113. 283 F. Supp. 2d 1018 (N.D. Iowa 2003). I served as an expert witness for the defendant
in this case.
114. Id. at 1024-25.
115. See id. at 1024.
116. Id. at 1023-24.
117. Id.
118. Perhaps Pioneer could have sued Ottawa on a theory of interference with contractual
relations. But the fact that Ottawa's conduct could be characterized as such interference only
emphasizes that it was not a proper subject of a patent infringement action.
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To conclude that the restriction was permissible, the court applied
the Mallinckrodt analysis, adding an additional step to turn the
restriction "only to produce forage or grain" into a "no resale"
restriction. First, it held that because the sale of the seed was
subject to the restriction, the sale was conditional and the exhaus-
tion doctrine did not apply.'19 Second, the court said that the
restriction of purchasers to a particular use-production for forage
or grain-was a denial of the right to all other uses, including the
right of resale. 2 ' Third, the court concluded that the defendant had
not raised an issue of fact regarding the validity of the restriction.
The court's analysis here, as in Lexmark, was cursory:
Pioneer's express limitation on any use other than production of
grain or forage, which reserves to Pioneer the right to sell the
invention, as stated, falls squarely within the patent grant. To
put it another way, the restrictions in the Pioneer "limited label
license" are "field of use restrictions," and such restrictions "are
generally upheld."12'
In this way, although the court expanded the Mallinckrodt analysis,
it did so without critical analysis.
Once again, the court did not examine the patent claims at issue.
It was undisputed that the seed corn was covered by the patents,
but that presumably did not determine whether the restriction itself
"relat[ed] to subject matter within the scope of the patent claims."'22
In any event, the farmers to whom the defendant ultimately sold the
corn complied with the restriction, planting the corn for forage or
grain and not to propagate future generations of the seed, which
was presumably the use that Pioneer sought to prevent. 123 Thus,
Pioneer's enforcement efforts were not even directed at an ultimate
use outside the restriction, but at the interposition of a reseller in
its distribution system.
119. Ottawa Plant Food, 283 F. Supp. 2d at 1031-35.
120. Id. at 1035-39.
121. Id. at 1045 (citing B. Braun Medical, Inc. v. Abbott Labs., 124 F.3d 1419, 1426 (Fed.
Cir. 1997), and Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 705 (Fed. Cir. 1992) ("[A]
restrictive license to a particular use is permissible.")).
122. Mallinckrodt, 976 F.2d at 708; see infra Part II.B.2.
123. See Ottawa Plant Food, 283 F. Supp. 2d at 1024.
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Admittedly, in the court's view the defendant had not sufficiently
alleged any anticompetitive effect of the restriction. The court said
that "[alt most, Ottawa asserts that Pioneer has imposed a prohibi-
tion on resale to discipline its licensed Sales Representatives and
licensed dealers and to maintain prices, but Ottawa has pointed to
no evidence demonstrating either such an intention or such an
effect of the limited label license.' '124 Given the court's conclusion
that the restriction was within the patent grant, however, any
anticompetitive effect would have been irrelevant under the
Mallinckrodt framework.
Moreover, it is unclear why simply using the property protections
of patent law to enforce contractual distribution restraints is not
anticompetitive. Antitrust law uses the rule of reason to strike a
balance between the procompetitive and anticompetitive aspects
of distribution restraints. 12 5 The rule of reason contemplates that
the restraints being assessed are contractual, not that they are
enforceable through property protections. Indeed, in early cases, the
Supreme Court objected to distribution restraints precisely because
they had the character of restraints on alienation.'26 Although the
Court no longer follows that approach, property enforcement has
additional substantive implications that can be anticompetitive, as
is discussed below.
127
3. The Monsanto Cases
In two other recent seed cases, Monsanto Co. v. McFarling 2 and
Monsanto Co. v. Scruggs,'29 the patentee sought to enforce some-
what similar restrictions, which prohibited the replanting of seed
124. Id. at 1046. It seems, though, that Ottawa could have alleged a tying violation,
claiming that the effect of the restriction was to require those who purchased Pioneer seed to
obtain sales services only from licensed Pioneer dealers. In that respect, the court might have
been incorrect in stating that "the 'limited label license' does not expressly or even impliedly
tie purchase or sale of Pioneer® brand seed corn to the purchase or sale of any other product."
Id. at 1045.
125. See, e.g., Gen. Talking Pictures Corp. v. W. Elec. Co., 305 U.S. 124 (1938); Bement v.
Nat'l Harrow Co., 186 U.S. 70 (1902).
126. See, e.g., Dr. Miles Med. Co. v. John D. Park & Sons Co., 220 U.S. 373, 404 (1911),
overruled by Leegin Creative Leather Prods., Inc. v. PSKS, Inc., 127 S. Ct. 2705 (2007).
127. See infra Part III.B.
128. 363 F.3d 1336 (Fed. Cir. 2004).
129. 342 F. Supp. 2d 568 (N.D. Miss. 2004), affld, 459 F.3d 1328 (Fed. Cir. 2006).
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harvested from the growth of the patented seed, against defendants
that had replanted the seed. These cases both built on each other
and expanded a patentee's ability to restrict downstream use. The
Federal Circuit's decision in McFarling raises some unique issues. 30
Furthermore, the district court in Scruggs ultimately relied on the
Federal Circuit's approval of the similar license in McFarling to
grant summary judgment to Monsanto. 131
In its decision on a motion for a preliminary injunction, however,
the district court in Scruggs relied on a different analysis. The
court began much as in the previous cases, with the statement
that the exhaustion doctrine does not apply to conditional
licenses.' Although the defendants argued that they never agreed
to the condition, the court rejected their argument, relying on
Mallinckrodt's statement that "a license notice may become a term
of sale, even if not part of the original transaction, if not objected to
within a reasonable time."' 3 As applied in these cases, this is not
obviously a correct statement of contract law.'
As in the other cases, the Scruggs district court determined that
the restriction was within the patent grant, but also provided some
analysis on this point:
In this case, the single use restriction does fall within the patent
grant. Given the fact that the gene technology at issue is passed
on to subsequent generations of seed, Monsanto's restriction to
the production of a single commercial crop is logically intended
to protect its patent monopoly and to thereby permit it to
capture revenue in the form of future sales of technology.
Without the prohibition against the saving of seed for replanting
or resale, Monsanto's patent would soon be rendered useless by
virtue of the potential for exponential multiplication of the seed
containing its patented technology. Given the risk of Monsanto's
thus losing control of its technology, the limited license of its
technology was the only reasonable alternative available to it if
it hoped to garner a reasonable return on its sizeable investment
130. See infra Part III.A.3.
131. Scruggs, 342 F. Supp. 2d at 584.
132. Monsanto Co. v. Scruggs, 249 F. Supp. 2d 746, 753 (N.D. Miss. 2001).
133. Id. at 754 (quoting Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 708 (Fed. Cir.
1992)).
134. See infra Part II.B.1.
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while making the technology available for commercial use at a
reasonable price to consumers. 3 5
Thus, the district court, unlike other courts, offered some actual
analysis of the restriction.
This analysis at least provides a test for the "within the patent
grant" inquiry: whether the restriction is necessary in order to reap
a reasonable return on the technology. Whether the facts of the
Scruggs case really met that test is unclear, given that the defen-
dants proposed an alternative that could have provided the patentee
with the same return and that was used by the patentee in other
countries. It is also unclear whether the need to reap a reasonable
return should be construed as an interest "within the patent grant,"
as the grant of a patent is not intended to guarantee the patentee a
particular return on his invention, but only to give him the right to
exclude others from certain unauthorized activities. Nevertheless,
the district court in Scruggs, unlike those in Lexmark and Ottawa
Plant Food, at least recognized the need to find an economic
justification for the restriction that the patentee imposed. 136
In any event, the court's reliance on McFarling in its later
summary judgment opinion eliminated this approach, and on
appeal the Federal Circuit also reverted to a formal approach.
Citing Mallinckrodt, the Federal Circuit categorically stated that
"[c]onduct falling within the scope of protection includes, inter alia,
limited use licensing,""' and, citing General Talking Pictures, stated
that "[f]ield of use licensing restrictions, i.e., permitting the use of
inventions in one field and excluding it in others, are also within the
scope of the patent grant." ''  Neither of those previous cases,
however, made the categorical statements for which the court cited
them.
In its evaluation of the enforceability of the no-replanting use
restriction, the Federal Circuit in Scruggs also stated:
135. Scruggs, 249 F. Supp. 2d at 753.
136. See id.
137. Monsanto Co. v. Scruggs, 459 F.3d 1328, 1338 (2006) (citing Mallinckrodt, 976 F.2d
at 703).
138. Id. (citing Gen. Talking Pictures v. Gen. Elec. Co., 305 U.S. 124, 127 (1938)).
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Monsanto has a right to exclude others from making, using, or
selling its patented plant technology, and its no replant policy
simply prevents purchasers of the seeds from using the patented
biotechnology when that biotechnology makes a copy of itself.
This restriction therefore is a valid exercise of its rights under
the patent laws. 139
This statement provides no analysis, however. Every field-of-use
restriction, if valid, "prevents purchasers... from using the patented
biotechnology [or other technology]. '"14' That statement merely
restates the problem; it does not provide a test for deciding whether
the restriction is valid. Even if the court meant to refer to the self-
replicating characteristic of seeds, a mere reference to that charac-
teristic does not explain its legal significance. The special problems
posed by self-replicating seeds are discussed below.'
In another respect, the courts in Scruggs went even further. The
defendants challenged a Monsanto license term that prohibited
"engaging in any research or experimentation with 'Monsanto
Know-How And Biological Material' or 'Licensed Patent Rights."'142
The district court concluded that this was simply a field-of-use
restriction, which seems reasonable given that the limitation was
confined to Monsanto's own materials. The Federal Circuit, how-
ever, consistently referred to the restriction as one "prohibiting
research or experimentation," with no reference to the application
to Monsanto's own materials, and it stated that "the no research
policy is a field of use restriction and is also within the protection of
the patent laws."'43 In combination with the other categorical
statements of the Federal Circuit in the case, this statement
reinforces the view that the Federal Circuit has abandoned any
scrutiny of use licensing.
139. Id. at 1340 (citation omitted).
140. Id.
141. See infra Part IV.B.3.
142. Monsanto Co. v. Scruggs, 342 F. Supp. 2d 568, 575 (N.D. Miss. 2004), affd, 459 F.3d
1328 (Fed. Cir. 2006).
143. Scruggs, 459 F.3d at 1340.
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B. Shortcomings in the Courts' Contract and Patent Analyses
The cursory nature of the courts' analyses in the cases discussed
above" is hard to explain. It seems that the combination of contract
law and patent law in the cases prevented the courts from carefully
focusing on either body of law. The courts did not carefully analyze
the contract claims, perhaps because the cases were fundamentally
about patent infringement. Further, the courts did not carefully
analyze the patent claims, perhaps because the alleged infringer
had breached a contract that was, formally at least, a patent license,
which therefore indicates patent infringement. This Section
attempts to examine closely both the contract and patent shortcom-
ings inherent in the courts' analyses.
1. Contract Analysis
The "single use only" restriction in Mallinckrodt was embodied
in a notice on the patented product, but there was no clear act of
consent to the restriction by the purchasers. 4 ' This is typical of
the other recent U.S. cases. For example, in Pioneer Hi-Bred
International, Inc. v. Ottawa Plant Food, Inc.,'46 the basis of the
contract was again a notice on the products sold, which in that case
were bags of corn seed. The same was true in Monsanto Co. v.
McFarling'47 and Monsanto Co. v. Scruggs,' where cotton and
soybean seeds were at issue.
The key problem in the courts' contract analyses in these cases
is that, generally speaking, notice of the terms that a seller would
like to impose is not sufficient to establish a contract on the basis
of those terms. This point was recognized by the Federal Circuit
in Hewlett-Packard Co. v. Repeat-O-Type Stencil Manufacturing
Corp.:149
144. See supra Part II.A.
145. See supra notes 40-50 and accompanying text.
146. 283 F. Supp. 2d 1018 (N.D. Iowa 2003).
147. 363 F.3d 1336 (Fed. Cir. 2004).
148. 342 F. Supp. 2d 568 (N.D. Miss. 2004), affd, 459 F.3d 1328 (Fed. Cir. 2006).
149. 123 F.3d 1445 (Fed. Cir. 1997).
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The question is not whether the patentee at the time of sale
intended to limit a purchaser's right to modify the product....
Each case turns on its own particular facts, but a seller's intent,
unless embodied in an enforceable contract, does not create a
limitation on the right of a purchaser to use, sell, or modify a
patented product as long as a reconstruction of the patented
combination is avoided. A noncontractual intention is simply the
seller's hope or wish, rather than an enforceable restriction.50
In Repeat-O-Type, however, the patentee had simply included a
package insert that, in the court's words, "suggest[ed]" the paten-
tee's desired restriction. 5' Therefore, although the court's refusal to
enforce the restriction appeared to turn on the lack of any assent to
it by the purchaser, it could also have been a product of a more
equivocal notice than those at issue here.
In any event, in Mallinckrodt, where the "single use only" notice
was clear (and thus perhaps more than a "suggestion"), the Federal
Circuit took an entirely different approach. It held that "a license
notice may become a term of sale, even if not part of the original
transaction, if not objected to within a reasonable time."'52 In this
respect, Mallinckrodt relied on section 2-207 of the Uniform
Commercial Code, adopted in most U.S. states. Section 2-207 is
designed to address the "battle of the forms" created in sales of
goods when contracting parties exchange documents with different
terms.'53 Under this section, as Mallinckrodt says, a restriction
"may become a term of sale" without explicit assent under certain
circumstances. 1
54
For several reasons, however, the circumstances in which this
"may" happen do not include the circumstances in these field-of-use
cases. First, section 2-207(2), to which the Mallinckrodt court refers,
is directed at exchanges of writings with different terms. 155 It is not
clear that the patent cases discussed here should even be viewed as
involving the exchanges of communications to which section 2-207
150. Id. at 1453.
151. Id.
152. Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 708 n.7 (Fed. Cir. 1992) (citing
U.C.C. § 2-207(2)(c)).
153. U.C.C. § 2-207 cmt. n.1 (2004).
154. Mallinckrodt, 976 F.2d at 708 n.7.
155. U.C.C. § 2-207(1) (2004).
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applies. The specific types of communications referred to by
section 2-207 are a "definite and seasonable expression of accep-
tance or a written confirmation which is sent within a reasonable
time."'56 A notice on a product, as in Mallinckrodt or Ottawa, may
be neither. Such notices do not even possess the legal character of
terms printed on the boxes in the shrink-wrap license cases.' This
distinction matters, because receipt of a written statement express-
ing contract terms puts the purchaser on notice of contractual
implications in a way that a simple notice on a product does not.'
Second, even if the notices met this requirement and, in the
language of section 2-207, were sufficient to be "construed as
proposals for addition to the contract,"'59 not all such proposals
become part of the contract. One way in which they may not is
referred to by Mallinckrodt: section 2-207(2)(c) says proposals do not
become part of the contract if the receiving party objects, and
Mallinckrodt suggested that the absence of an objection could
form a contract. 6 1 Section 2-207(2)(b), however, which Mallinckrodt
ignored, also requires that additional terms do not become part of
the contract between merchants if "they materially alter it,"
regardless of whether an objection is made.' 6 ' The restrictions at
issue here-limiting the purchaser to a single use or eliminating the
right of resale--certainly seem to materially alter the contract.
Moreover, if the sales are to non-merchants, like individual con-
sumers, as some were in Lexmark, section 2-207 provides that the
additional terms do not become part of the contract in any case.'62
Despite the observation of the Federal Circuit in Repeat-O-Type
that a use restriction requires an enforceable contract, the lower
156. Id.
157. See infra Part III.B.
158. As a result, the transactions at issue in the patent cases might actually involve
acceptance by conduct, which is governed by a different subsection, U.C.C. § 2-207(3) (2004).
That subsection provides that "the terms of the particular contract consist of those terms on
which the writings of the parties agree, together with any supplementary terms incorporated
under any other provisions of [the Uniform Commercial Code]." Id. Thus, the use restrictions
in these cases would not become part of the contract under this subsection.
159. U.C.C. § 2-207(2) (2004).
160. Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 708 n.7 (Fed. Cir. 1992).
161. See U.C.C. § 2-207(2)(b) (2004).
162. Id. In Lexmark, the use restriction prohibited the refilling of laser printer toner
cartridges, and the restriction was printed on the cartridge packaging. Ariz. Cartridge Remfrs.
Ass'n, Inc. v. Lexmark Int'l, Inc., 421 F.3d 981, 983-84 (9th Cir. 2005).
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courts in these field-of-use cases did not actually engage in a careful
determination of whether such contracts existed. This is especially
evident in the preliminary injunction opinion in Monsanto Co. v.
Scruggs,'63 which was relied upon by Ottawa. Ottawa correctly
described Scruggs as holding that:
[Blecause the defendants had known about the restrictions on
the use of the seed, from various sources, including the labels
and trade journals, their failure to contest the terms of the
license within a reasonable time after the sale suggested that
Monsanto's licensing conditions became enforceable terms of the
sale."
It is simply not true, however, that a patentee can impose contrac-
tual terms on a purchaser by publishing those terms in labels or
trade journals, even if the purchaser sees those terms.
A critical point in these cases is whether the terms were provided
to the purchaser before or after the purchase. Both Mallinckrodt
and Scruggs treated the terms as provided after the sale,'65 which
distinguishes them from the typical shrink-wrap cases, and from
Lexmark.'66 When terms are provided after the sale, the patentee
cannot argue, as the copyright owners did in the shrink-wrap cases,
that the purchaser accepted the terms in the initial sale transaction
itself. Thus, the patentee must rely instead on section 2-207, which
provides purchasers the protections described above.167
These issues were discussed more carefully in an analogous
case, Step-Saver Data Systems, Inc. v. Wyse Technology,6 ' which
involved copyright rather than patent law. The additional terms in
Step-Saver were printed on the box of software that was the subject
of a telephone-and-mail transaction.'69 The copyright owner, TSL,
argued that the additional terms-denials of warranties-were
163. 249 F. Supp. 2d 746 (N.D. Miss. 2001), affid, 459 F.3d 1328 (Fed. Cir. 2006).
164. Pioneer Hi-Bred Intl, Inc. v. Ottawa Plant Food, Inc., 283 F. Supp. 2d 1018, 1047
(N.D. Iowa 2003) (citing Monsanto Co. v. Scruggs, 249 F. Supp. 2d 746, 754 (N.D. Miss. 2001)).
165. See supra notes 146, 150-55, 164 and accompanying text.
166. See infra notes 176-78 and accompanying text.
167. See supra notes 154-63 and accompanying text.
168. 939 F.2d 91 (3d Cir. 1991).
169. Id. at 93-94.
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binding upon the purchaser, Step-Saver.17 ° In addition to holding
that the denials of the warranties would materially alter the
contract and thus would not bind Step-Saver without its assent, the
court drew the critical distinction between notice and assent that
eluded the Mallinckrodt and Ottawa courts:
Given TSL's failure to obtain Step-Saver's express assent to
these terms before it will ship the program, Step-Saver can
reasonably believe that, while TSL desires certain terms, it has
agreed to do business on other terms-those terms expressly
agreed upon by the parties. Thus, even though Step-Saver would
not be surprised to learn that TSL desires the terms of the box-
top license, Step-Saver might well be surprised to learn that the
terms of the box-top license have been incorporated into the
parties' agreement. 7'
The contrast between the careful analysis in Step-Saver, which
continues over ten pages of the printed opinion,172 and the one- or
two-sentence conclusory statements in the patent cases is striking
and hard to explain.'73 Perhaps the dichotomy derives from the fact
that in the patent cases, the use restrictions at issue seem more like
issues of patent law than contract law, in contrast to the warranty
disclaimers in Step-Saver. Contract law is essential to these cases,
however, and the courts should not impose 'license" conditions on
purchasers without carefully determining whether there is, in fact,
a license.
It is true that courts have upheld various instances of "shrink-
wrap" and "click-wrap" licenses, though largely in the copyright
context.74 The courts that have done so, however, generally relied
upon the availability of the terms to the purchasers at the time of
sale; on a requirement that the purchaser acknowledge his aware-
170. Id. at 97-98.
171. Id. at 104.
172. Id. at 96-106.
173. In addition, although contract law is state law, these cases do not turn to the law of
the states to resolve the license questions. See Rhone-Poulenc Agro, S.A. v. DeKalb Genetics
Corp., 284 F.3d 1323, 1327 (Fed. Cir. 2002) ("In general, the Supreme Court and this court
have turned to state law to determine whether there is contractual 'authority' to practice the
invention of a patent. Thus, the interpretation of contracts for rights under patents is
generally governed by state law.").
174. See infra Part III.B.
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ness of the license terms (typically by responding to a computer
program inquiry); and on the opportunity for the purchaser to
decline the terms (sometimes by returning the product). In
Mallinckrodt, Ottawa, and Scruggs, the terms were simply printed
on the products or packaging, and it is not clear that the purchasers
either knew of the terms at the time of the purchase or had the
option to return the products if they did not accept the conditions.
The only recent case that arguably might meet such conditions is
Lexmark, where the term was a prohibition on refilling a laser
printer toner cartridge.'75 Because the term was printed on the
toner cartridge package, the only acknowledgment of the term
would occur through the purchase or the opening of the package.
But the notice on the package offered purchasers the option of
returning the package to the seller, an option upon which courts
have relied in finding contractual consent in the shrink-wrap
cases.'76 In addition, the package notice also explained that
Lexmark offered buyers the option of paying a higher price for a
cartridge that they were permitted to refill.' The other cases
lacked even these limited indications of the consent of buyers.
2. Patent Analysis
Even if the buyers of these patented products entered into valid
license contracts with the patentees, it is not clear that those
contracts should have been enforceable. Mallinckrodt left open the
possibility that a field-of-use license might go beyond the scope of
the patent claims, but the courts considering these issues generally
have not given that possibility serious consideration. As described
above, the lower courts generally have relied on the mere existence
of the patents and on the courts' views that the purchasers have
assented to the restrictions. 78 At most, the courts have adverted
to the statement in B. Braun Medical that "express conditions
accompanying the sale or license of a patented product are generally
175. Ariz. Cartridge Remfrs. Ass'n, Inc. v. Lexmark Int'l, Inc., 421 F.3d 981, 983-84 (9th
Cir. 2005).
176. See id.
177. Id. at 984.
178. See supra Part II.B.1.
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upheld." '179 Additionally, the Federal Circuit in Scruggs apparently
held that all field-of-use licenses are within the scope of the
applicable patents. 8 °
Thus, the courts have not meaningfully followed the Federal
Circuit's initial statement in Mallinckrodt that in order to be
enforceable, a field-of-use license must be "reasonably within the
patent grant."'18 Instead, these courts have generally required
nothing more than a reference to the patents at issue and to the
contractual field-of-use restriction. This approach conflates the
patent and contract inquiries. As argued below, the proper approach
is to maintain the independence of the patent inquiry by focusing on
the boundaries both of the patents at issue and of patent protection
itself.182
III. FIELD-OF-USE LICENSING AND THE SCOPE OF PATENT
INFRINGEMENT
The Federal Circuit recast the question of whether a use restric-
tion is within the scope of the patent claim into the question of
whether "the patentee has 'impermissibly broadened the "physical
or temporal scope" of the patent grant with anticompetitive
effect.""83 A patent's scope, however, is defined by more than the
"physical" products its claims cover and the "temporal" period of its
coverage. Its scope is also defined by the classes of conduct that the
patent can be used to prohibit."8 It may be possible for a patentee
to impermissibly broaden the scope of acts that constitute infringe-
ment, not just the coverage of the patent. As this Part explains, in
several of the lower court cases at issue there would be no infringe-
ment in the absence of the use restrictions, even if there were no
179. B. Braun Med., Inc. v. Abbott Labs., 124 F.3d 1419, 1426 (Fed. Cir. 1997); see, e.g.,
Lexmark, 421 F.3d at 986-87 ("A restriction on a patented use is permissible as long as it is
'found to be reasonably within the patent grant." (quoting Mallinckrodt, Inc. v. Medipart, Inc.
976 F.2d 700, 708 (Fed. Cir. 1992))).
180. See supra notes 138-39 and accompanying text.
181. Mallinckrodt, 976 F.2d at 708.
182. See infra Part III.
183. B. Braun, 124 F.3d at 1426 (quoting Windsurfing Int'l, Inc. v. AMF, Inc., 782 F.2d 995,
1001-02 (Fed. Cir. 1986)).
184. See generally ROGER E. SCHECHTER & JOHN R. THOMAS, PRINCIPLES OF PATENT LAW
275-95 (2004) (discussing the scope and infringement of patent rights).
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license. 185 Patentees were able to transform permissible conduct into
infringement only by adoption of the use restrictions.186
This Part argues that the broadening of the scope of infringement
can be prevented by first requiring an independent infringement
inquiry. That is, at the threshold, the court should conduct an initial
inquiry into whether the patent at issue is infringed, without regard
to whether the alleged infringer has consented to a field-of-use
license. If the conduct at issue would not be infringement in the
absence of the license, as would be the case for permissible repair,
a breach of a contract should not constitute patent infringement.
Patent law authorizes a patentee to sue any party that "without
authority makes, uses, offers to sell, or sells any patented invention,
within the United States, or imports into the United States any
patented invention. 187 Because these cases involve "use" licensing,
one would expect that the scope of the prohibition on the unautho-
rized "use" of the invention would be at issue. In fact, however, the
particular conduct challenged in most of these cases is better
characterized as "making" the invention, rather than "using" it. For
example, in Mallinckrodt, the alleged infringer, Medipart, did not
itself use the patented products, but only reconditioned them for
hospitals.'88 Similarly, in Lexmark the parties to the litigation were
remanufacturers of the patented toner cartridges, not the ultimate
users of the cartridges."8 9 And in Ottawa Plant Food, the defendant
was simply a reseller of the patented product; it neither used nor
185. See infra Part III.A.
186. The general approach of the analysis here is similar to that in Kobak, supra note 25,
at 559-64, in that it focuses on the use of contract to escape substantive limitations of patent
law. The scope of this phenomenon has in recent years increased dramatically beyond that in
the immediate post-Mallinckrodt period in which Kobak was writing. See supra Part II.A.
The use of state contract law to extend patent protection could also be viewed as a
preemption issue, as it has in the software context. See John E. Mauk, Note, The Slippery
Slope of Secrecy: Why Patent Law Preempts Reverse-Engineering Clauses in Shrink-Wrap
Licenses, 43 WM. & MARY L. REV. 819, 819-20 (2001). But a proper application of the limits of
patent law would eliminate the preemption problem by eliminating the extension of
protection. Cf. Mark A. Lemley, Beyond Preemption: The Law and Policy of Intellectual
Property Licensing, 87 CAL. L. REV. 111, 138-44 (1999) (discussing the trouble with fitting
preemption rules into an intellectual property context).
187. 35 U.S.C. § 271(a) (2006).
188. Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 702 (Fed. Cir. 1992).
189. Ariz. Cartridge Remfrs. Ass'n, Inc. v. Lexmark Int'l, Inc., 421 F.3d 981, 983-84 (9th
Cir. 2005).
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made the product. 9 ° Thus, despite the fact that the license restric-
tions at issue in these cases were termed "field-of-use" restrictions,
the forms of infringing conduct in these cases were the "making"
and the "selling," not the "using," of the patented products.
Of course, in normal language both making and selling might be
construed as uses of a product. Nevertheless, the fact that the
statute distinguishes among these various activities suggests
caution before treating them as one. The next two Sections will
demonstrate that by failing to exercise such caution, the courts have
permitted patentees to transform permissible making and selling
into impermissible using. Additionally, the third Section illustrates
another problem with this approach: it allows for the avoidance of
difficult policy decisions regarding the nature of infringement by
making even ambiguous conduct simply an impermissible "use."
A. The Scope of Infringement
1. Making and Repair
When a patentee alleges that another is liable for infringing its
patent by making the invention, an essential question should be
whether the "making" of the invention is permissible under patent
law.'9 ' If so, there can be no infringement regardless of whether
there is a violation of a use restriction. Therefore, the first question
in these cases should ask whether an infringing act exists independ-
ent of the licensing restriction. If not, the violation of a use restric-
tion might be a breach of contract, but even a breach of the contract
would not constitute infringement.
The repair issue was central to several of the field-of-use cases.
For example, in Lexmark and Mallinckrodt, the allegedly infringing
acts involved arguable "makings" of inventions.'92 By refilling toner
cartridges or sterilizing and repackaging nebulizers, the alleged
infringers in those cases arguably "made" new toner cartridges
and nebulizers, respectively.'93 These "makings" of the inventions,
190. Pioneer Hi-Bred Int'l, Inc. v. Ottawa Plant Food, Inc., 283 F. Supp. 2d 1018, 1024
(N.D. Iowa 2003).
191. See SCHECHTER & THOMAS, supra note 184, at 276-78.
192. See Lexmark, 421 F.3d at 983-84; Mallinckrodt, 976 F.2d at 702.
193. See Lexmark, 421 F.3d at 983-84; Mallinckrodt, 976 F.2d at 702.
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however, might have been permissible because they were repairs of
the patented inventions. In Aro 1, 9 the Supreme Court held that
purchasers of patented products have the right to repair those
products:
[A] lthough there is no right to "rebuild" a patented combination,
the entity "exists" notwithstanding the fact that destruction or
impairment of one of its elements renders it inoperable; and
that, accordingly, replacement of that worn-out essential part is
permissible restoration of the machine to the original use for
which it was bought.'95
That is, although "rebuilding" a patented product is infringement,
the Supreme Court placed repair outside the boundary of infringing
activity, as is illustrated in Figure 1.
making competing product
making new product by designing around
incorporating invention invention
"rebuilding" existing product
incorporating invention repairing existing product
incorporating invention
/
boundary of infringing activity
Figure 1. Infringement for "making," as defined by 35 U.S.C.
§ 271 and the Supreme Court.
194. Aro Mfg. Co. v. Convertible Top Replacement Co. (Aro 1), 365 U.S. 336 (1961).
195. Id. at 342 (citing Wilson v. Simpson, 50 U.S. (9 How.) 109, 123 (1850)). The focus in
both Aro I and in Wilson v. Simpson was on inventions that were combinations of components.
Aro I, 365 U.S. at 337-38; Wilson, 50 U.S. (9 How.) at 110.
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In Mallinckrodt, however, the Federal Circuit held that a
patentee can eliminate the right of repair by contract.19 To reach
this conclusion, Mallinckrodt relied on the Supreme Court's holding
in Aro I19 that application of the repair doctrine requires that the
initial sale of the product be authorized.9 ' Because the initial sale
of the nebulizers to the hospitals was authorized in Mallinkrodt,
however, and the only conduct that was arguably unauthorized was
the reconditioning1 9 -whose validity turns precisely on the repair
doctrine-the Federal Circuit's reasoning constitutes impermissible
bootstrapping.
The unauthorized conduct in Aro H was the unlicensed manu-
facture of the patented product,200 which would have been
unauthorized regardless of whether the purchasers of the products
subsequently repaired them. In contrast, the Mallinckrodt court
concluded that the initial sale might have been unauthorized only
by relying on its conclusion that the subsequent repair might have
been unauthorized, depending on whether a contract was formed
eliminating the right of repair. This analysis impermissibly reverses
the inquiry, making the validity of the original sale turn on the
permissibility of repair rather than vice versa, as the Supreme
Court held.
When Mallinckrodt's holding, which allowed the right of repair to
be eliminated by contract, is combined with the Federal Circuit's
view that conduct by the licensee that is outside the scope of the
license is patent infringement,201 the Federal Circuit has redefined
the scope of infringement for "making" the patented product, as
shown in Figure 2.
196. Mallinckrodt, 976 F.2d at 709.
197. Aro Mfg. Co. v. Convertible Top Replacement Co. (Aro 11), 377 U.S. 476 (1964).
198. Mallinckrodt, 976 F.2d at 709 (quoting Aro II, 377 U.S. at 480).
199. See id.
200. Aro II, 377 U.S. at 482.
201. See Mallinckrodt, 976 F.2d at 707 n.6 ("[T]he remedy for breach of a binding license
provision is not exclusively in contract, for a license is simply a promise not to sue for what
would otherwise be patent infringement.") (citations omitted).
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making new product making competing product
incorporating invention by designing around
invention
rebuilding" existing product repairing existing product
incorporating invention incorporating invention
repairing existing product if
prohibited by license,
which creates use outside
the scope of the license,
which is infringement
old boundary of infringing activity new boundary of infringing activity
Figure 2. Infringement for "making," as redefined by the Federal
Circuit.
No doubt the Federal Circuit does not view itself as rewriting
section 271 of the Patent Act as it has been interpreted by the
Supreme Court's repair cases. °2 Instead, it presumably views the
right of repair as something akin to an implied license." 3 Under
that view, repairing a patented product would always be infringe-
ment statutorily, but it would sometimes be licensed by the
patentee. The problem is that there is no support in the Supreme
Court's decisions for the implied-license interpretation. The Court
in Aro I was quite explicit: "'The [patent] monopolist cannot prevent
those to whom he sells from ... reconditioning articles worn by use,
202. This section defines infringement. 35 U.S.C. § 271 (2006).
203. The district court in Lexmark appeared to take this position: "In the case of a
conditional sale, the purchaser does not receive the same implied license that the purchaser
in an unconditional sale receives. Thus, where the purchaser of an unconditional sale has
every right to repair the device, the purchaser of a conditional sale does not." Ariz. Cartridge
Remfrs. Ass'n, Inc. v. Lexmark Int'l, Inc., 290 F. Supp. 2d 1034, 1043 (N.D. Cal. 2003). The
Lexmark court cited Mallinckrodt for this approach, but Mallinckrodt did not adopt it, at least
not explicitly. See Mallinckrodt, 976 F.2d at 709.
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unless they in fact make a new article.""'2 4 Although the Federal
Circuit presumably would take the view that because the license is
conditional there is no "sale," the Supreme Court's decisions provide
no support for this view.
The Supreme Court has never decided whether a patentee may
contractually eliminate the right of repair. There were four separate
opinions in Aro I, and each of them focused on the substantive
nature of the repair-reconstruction inquiry rather than on any
freedom of the patentee to limit the repair right.2 °5 Furthermore, the
Court appeared to say that the patentee may not single out the
repair right from other aspects of the invention: "[A] license to use
a patented combination includes the right 'to preserve its fitness
for use so far as it may be affected by wear or breakage."'20 6 This
statement seems to indicate that if the patentee chooses to license
its product at all, it cannot retain the right to repair it.
Moreover, the Court considered a case similar to Mallinckrodt
and declined to afford the patentee the right to contractually limit
the right to repair. In American Cotton-Tie Co. v. Simmons, °7 the
Court was faced with the sale of cotton bale ties, on which were
stamped the words "Licensed to use once only."2 Although the
Court held that the defendant had infringed the patent, it reached
that conclusion through a careful analysis of the patent and the
204. Aro Mfg. Co. v. Convertible Top Replacement Co. (Aro 1), 365 U.S. 336, 343 (1961)
(quoting United States v. Aluminum Co. of Am., 148 F.2d 416, 425 (2d Cir. 1945)).
205. Justice Brennan's concurring opinion offered a list of factors that he thought
important in the repair determination:
Appropriately to be considered are the life of the part replaced in relation to the
useful life of the whole combination, the importance of the replaced element to
the inventive concept, the cost of the component relative to the cost of the
combination, the common sense understanding and intention of the patent
owner and the buyer of the combination as to its perishable components,
whether the purchased component replaces a worn-out part or is bought for
some other purpose, and other pertinent factors.
Id. at 363-64 (Brennan, J., concurring) (footnotes omitted). It is notable here that although
Justice Brennan refers to the intention of both the patentee and the buyer, his reference is
to their "common sense" intention, not to their contractual intention. Id.
206. Id. at 345 (majority opinion) (quoting Leeds & Catlin Co. v. Victor Talking Mach. Co.,
213 U.S. 325, 336 (1909)); see also id. at 369 ('The underlying rationale of the rule is of course
that the owner's license to use the device carries with it an implied license to keep it fit for
the use for which it was intended, but not to duplicate the invention itself.") (Harlan, J.,
dissenting).
207. 106 U.S. 89 (1882).
208. Id. at 91.
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relationship of the defendant's activities to the claims. °9 After the
original description of the words stamped on the product, the Court
did not mention them further.
By virtue of its exposure to the issue in Cotton-Tie, the possibility
of a patentee's attempt to limit the right of repair was certainly
before the Court in Aro I. Moreover, each of the four Aro I opinions
mentioned the Cotton-Tie case, 10 but none suggested that the repair
right could be denied by contract. The majority did say that the
"Licensed to use once only" stamp "was deemed of importance by the
Court," '' but it is unclear on what that statement was based, given
the absence of any discussion of the issue in Cotton-Tie. Indeed,
Justice Harlan responded that although "the Court there [in Cotton-
Tie] did refer to the fact that the original ties were stamped 'Li-
censed to use once only,' it is manifest that nothing really turned on
that point."2 2
Thus, a fair reading of the Supreme Court's opinions reveals no
support for a contractual elimination of the right of repair. Because
the Court has never decided the issue, however, it is again worth
considering the law in Europe, where recent cases from two
European countries reflect an approach closer to that of the U.S.
Supreme Court than that of the Federal Circuit. The repair issue
was explored in the 2004 Fliigelradzdhler decision of the German
Federal Supreme Court.13 Taking a substantive approach, the court
stated that the repair-reconstruction determination requires a
balancing of the patentee's interest in the exploitation of its
209. Id. at 90-95.
210. Aro 1, 365 U.S. at 343 n.9, 346; id. at 355-56 (Black, J., concurring); id. at 364 n.7, 367
(Brennan, J., concurring); id. at 369 (Harlan, J., dissenting).
211. Id. at 343 n.9 (majority opinion).
212. Id. at 374 n.3 (Harlan, J., dissenting); see also id. at 356 (Black, J., concurring)
(discussing Cotton-Tie and observing that "[m]arked on each [cotton bale tie], for whatever it
was worth, was 'Licensed to use once only.-).
213. See Bundesgerichtshof [BGH] [Federal Court of Justice] May 4, 2004, Gewerblicher
Rechtsschutz und Uhreberrecht [GRUR] 758 (Case No. X ZR 48/03 (F.R.G.). An English
translation of this decision appears at Decisions, Germany, "Means Within Patent Act, Sec.
10-Whether Replacement of Parts of Device is Equivalent to Making the Device-X ZR
48/03-"Impeller Flow Meter" 36 IIC: INT'L REV. OF INTELL. PROP. & COMP. L. 963 (2005)
[hereinafter Impeller Flow Meter]. The case is also discussed in Niels Holder, Contributory
Patent Infringement and Exhaustion in Case of Replacement Parts - Comment on a Recent
Supreme Court Decision in Germany, 36 IIC: INT'L REV. OF INTELL. PROP. & Comp. L. 889
(2005).
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invention and the purchaser's interest in the unhindered use of it.214
More specifically, the court said that a replacement of parts is
permissible if they are parts "that usually must be replaced-
possibly several times-during the expected working life of a
machine." '215 On the other hand, the replacement is impermissible
if the "part implements the technical or commercial benefit of the
invention a second time."21
Although the court in Fliigelradzdhler was not confronted with an
attempt to restrict the repair right through contract, like the U.S.
Supreme Court in Aro I it referred to the right of repair as a part of
the right to use the invention: "It is true that the use of a patented
product as intended also includes the maintenance and re-establish-
ment of usability if the function or performance of the specific
product is impaired or lost in whole or in part by wear or damage or
on other grounds. 217 The court went further than Aro I, however, by
suggesting that the right of the patentee to deny its consent to
repair would turn on the specific nature of the invention. The court
stated that although the public's expectation of a right to repair
"may generally exist and be justified, it is unfounded if such a
switch is impossible without the patent holder's consent precisely
because of the protection applying to a specific impeller flow
meter."21 In other words, the patentee's ability to deny the right of
repair depends on the nature of the invention, not just "[t]he mere
fact that the [patentee] expressly refers to its patent protection." '219
Furthermore, a recent decision by the House of Lords in the
United Kingdom, United Wire Ltd. v. Screen Repair Services
(Scotland) Ltd.,220 is more explicit, addressing the contract issue
directly:
Repair is one of the concepts (like modifying or adapting) which
shares a boundary with "making" but does not trespass upon its
territory. I therefore agree with the Court of Appeal that in an
214. See Impeller Flow Meter, supra note 213, at 969.
215. Id. at 969-70.
216. Id. at 970.
217. Id. at 969.
218. Id. at 968 (emphasis added).
219. Id. The argument that the permissibility of a use restriction should turn on the nature
of the patentee's inventive contribution is taken up later in this Article. See infra Part IV.A.2.
220. 2000 E.N.P.R. 324 (H.L.).
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action for infringement by making, the notion of an implied
licence to repair is superfluous and possibly even confusing. It
distracts attention from the question raised by section 60(1)(a),
which is whether the defendant has made the patented product.
As a matter of ordinary language, the notions of making and
repair may well overlap. But for the purposes of the statute, they
are mutually exclusive. The owner's right to repair is not an
independent right conferred upon him by licence, express or
implied. It is a residual right, forming part of the right to do
whatever does not amount to making the product.22'
This decision makes clear that at least in the United Kingdom,
the Federal Circuit's approach of allowing the contractual elimina-
tion of the repair right is unacceptable. On the contrary, because
repair is conduct outside the scope of patent infringement, no
consent is needed by purchasers for repair; if they agreed to cede
that right by contract, any breach of the resulting contract would
not constitute patent infringement. Analytically, United Wire pro-
vides a much sounder approach to the repair issue than the
contractual approach of Mallinckrodt, especially in light of the
casual approach to finding a contract that has prevailed in the
United States.
2. Selling and Reselling
In Ottawa Plant Food,222 the allegedly infringing act was a resale
of the patented product. Prior to Ottawa, however, the reselling of
a patented product was not viewed as "selling" (or "using") the
product for infringement purposes. On the contrary, although less
explicit on this issue than courts of other jurisdictions, the Supreme
Court has on several occasions made clear that there is no infringe-
ment liability for resales of patented goods.223 Thus, the legal
framework was that shown in Figure 3.
221. Id. at 329.
222. Pioneer Hi-Bred Int'l, Inc. v. Ottawa Plant Food, Inc., 283 F. Supp. 2d 1018 (N.D. Iowa
2003).
223. See supra note 54 and accompanying text.
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Figure 3. Infringement for "selling," as defined by the exhaustion
doctrine.
By defining a resale as a "use" and allowing the patentee to
eliminate the right to that use with a "field-of-use" license, 24 Ottawa
redefined the boundaries of infringement for "selling" in a way
analogous to Mallinckrodt's redefinition of "making," resulting in
the situation shown in Figure 4.225
224. Ottawa Plant Food, 283 F. Supp. 2d at 1044-46.
225. See supra notes 192-202 and accompanying text.
selling competing non-
selling new product infringing product
incorporating invention
reselling existing, and
already purchased, product
incorporating invention
/
boundary of infringing activity
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selling competing non-
selling new product infringing product
incorporating invention
reselling existing, and
already purchased, product
incorporating invention, if
not prohibited by license
reselling existing, and
already purchased, product
incorporating invention, if
prohibited by license
old boundary of infringing activity new boundary of infringing activity
Figure 4. Infringement for "selling," as redefined by
Ottawa Plant Food.
As in Mallinckrodt, the Ottawa court surely did not view itself as
amending the patent laws, but as enforcing a license restriction. The
court made clear, however, that it was relying on the contractual
restriction to make the exhaustion doctrine inapplicable: "Ottawa
has failed to generate a genuine issue of material fact that the sale
of Pioneer® brand seed corn was not always conditional, so that, in
the face of undisputed evidence that the sales were conditional, the
'patent exhaustion' defense is simply inapplicable as a matter of
law." '226 Thus, the court effectively viewed the first-sale doctrine as
one of implied license, just as Mallinckrodt did with the repair
doctrine.
No court other than Ottawa Plant Food has gone so far as to allow
a patentee to eliminate the first-sale doctrine by contract, but
dictum in another recent case indicates that the Federal Circuit
agrees with this general approach. In Anton/Bauer, Inc. v. PAG,
226. Ottawa Plant Food, 283 F. Supp. 2d at 1033.
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Ltd.,227 the court said that "[t]he [Supreme] Court's statements in
[United States v. Univis Lens Co.] demonstrate how closely related
the exhaustion doctrine is to the grant of an implied license. Indeed,
they suggest that an implied license stems from the exhaustion of
a patent right. 228
If the court meant to suggest that the exhaustion doctrine is
merely an implied license that can be eliminated by the patentee, 29
that claim finds no support in Univis23° or in any other Supreme
Court decision. Indeed, in a case that, like Ottawa, involved a
purchaser's sales of patented goods outside the territory assigned to
the original seller, the Supreme Court made clear that an effort by
a patentee to restrict resale would be merely contractual and could
not support an infringement suit:
Whether a patentee may protect himself and his assignees by
special contracts brought home to the purchasers is not a
question before us, and upon which we express no opinion. It is,
however, obvious that such a question would arise as a question
of contract, and not as one under the inherent meaning and
effect of the patent laws.2 al
Additionally, the Court indicated in Univis, cited by the Federal
Circuit in Anton/Bauer, 32 that such contracts "derived no support
from the patent and must stand on the same footing under the
Sherman Act as like stipulations with respect to unpatented
commodities., 233 This statement seems clearly to reflect the view
that a patentee cannot change the rules of exhaustion by contract,
just as a patentee cannot deny the right of repair by contract. The
227. 329 F.3d 1343 (Fed. Cir. 2003).
228. Id. at 1350 (referencing United States v. Univis Lens Co., 316 U.S. 241 (1992)).
229. Alternatively, the statement might just reflect unintentional conflation of the implied
license and exhaustion doctrines. For an excellent discussion of the two doctrines that
illustrates how the Federal Circuit sometimes fails to maintain a distinction between them,
see Rufus J. Pichler, William I. Schwartz, & Stephen M. Obenski, Recent Developments in
the Law of Patent Exhaustion and Implied Licenses, Presentation at the 7th Annual
Advanced Patent Law Institute (Nov. 30 - Dec. 1, 2006) (on file with author).
230. Univis Lens Co., 316 U.S. 241.
231. Keeler v. Standard Folding Bed Co., 157 U.S. 659, 666 (1895).
232. Anton/Bauer, Inc., 329 F.3d at 1349-51.
233. Univis, 316 U.S. at 251 (citing Ethyl Gasoline Corp. v. United States, 309 U.S. 436,
456-57 (1940)). Although Univis involved resale price maintenance, the Court's reasoning in
that case is consistent with that in its cases addressing territorial restrictions.
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Ottawa court nevertheless expanded the scope of infringement to
encompass resales of patented products.23 4
Part of the problem here may stem from the Federal Circuit's
failure to distinguish between contracts and licenses. Despite the
Supreme Court's suggestion that patentees may use contracts to
impose restrictions on purchasers,2 35 that suggestion does not mean
that those contracts should be treated as patent licenses. Although
a patent license is a contract, not every contract is a patent license.
In fact, the Supreme Court in the passage quoted above from Keeler
used the term "contract" in this context, rather than "license. '236 As
another example, the Court in Motion Picture Patents referred to the
patentee's "contract" with the "purchaser or licensee. ' If every
contract were a license, the purchaser would be a licensee, and the
Court would have no need to distinguish the two. The Court has
maintained this contract/license distinction in patent cases of
various types.23
Interestingly, the Federal Circuit also apparently adopted this
distinction in at least one copyright case. In Bowers v. Baystate
Technologies, Inc.,239 the court concluded that "private parties are
free to contractually forego the limited ability to reverse engineer a
software product under the exemptions of the Copyright Act."24
This and other cases considering contractual eliminations of fair
use reverse-engineering rights are analogous to the contractual
expansions of patent protection discussed here. Bowers affirmed
only the breach of contract claim, however, without considering
234. See Pioneer Hi-Bred Int'l, Inc. v. Ottawa Plant Food Inc., 283 F. Supp. 2d 1018, 1033
(N.D. Iowa 2003) ("Ottawa has failed to generate a genuine issue of material fact that the sale
of Pioneer® brand seed corn was not always conditional, so that, in the face of undisputed
evidence that the sales were conditional, the 'patent exhaustion' defense is simply inapplicable
as a matter of law.").
235. See supra note 34 and accompanying text.
236. See supra notes 232, 234 and accompanying text.
237. Motion Picture Patents Co. v. Universal Film Mfg. Co., 243 U.S. 502, 509 (1917).
238. See, e.g., Aronson v. Quick Point Pencil Co., 440 U.S. 257, 263-65 (1979); Lear, Inc. v.
Adkins, 395 U.S. 653, 669-75 (1969) (using "contract" when referring to state-law contract
rights and "license" when referring to patent rights); Mercoid Corp. v. Mid-Continent Inv. Co.,
320 U.S. 661, 666 (1944) ("When the patentee ties something else to his invention, he acts
only by virtue of his right as the owner of property to make contracts concerning it and not
otherwise. He then is subject to all the limitations upon that right which the general law
imposes upon such contracts.").
239. 320 F.3d 1317 (Fed. Cir. 2003).
240. Id. at 1325-26.
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copyright infringement; the court even suggested, though somewhat
obscurely, that the contract might not change the limits of copyright
law. 241
In its own area of patent law, the Federal Circuit has been less
discriminating. Thus, the court is incomplete in stating that "the
remedy for breach of a binding license provision is not exclusively
in contract, for a license is simply a promise not to sue for what
would otherwise be patent infringement." '42 Although that state-
ment may be true, the Supreme Court indicated that the critical
question is whether a particular contract is in fact a license to which
that statement should apply.243 If so, the breach of the license is
indeed patent infringement. If not, the remedy is exclusively in
contract.
3. Self-Replicating Products
As noted above,244 the Federal Circuit's approach in Monsanto
Co. v. McFarling45 was different in some respects from the other
cases discussed here. The restriction at issue in McFarling, which
was similar to the one in Scruggs, required that those purchasing
Monsanto's seed enter into an agreement under which they would
use the seed "for planting a commercial crop only in a single season"
and would "not save any crop produced from this seed for replant-
ing, or supply saved seed to anyone for replanting. '2 46 The effect of
the restriction in both cases was to prevent growers from propagat-
ing the seeds containing Monsanto's patented inventions for sale.
Although the plaintiff in McFarling argued that the restriction on
replanting was a field-of-use restriction, the Federal Circuit rejected
that characterization because the grower used the patented seed in
the same way regardless of whether he replanted the new seeds.247
The court pointed out that instead of restricting the use of the
241. Id. at 1326 ("[A] party bound by such a contract may elect to efficiently breach the
agreement in order to ascertain ideas in a computer program unprotected by copyright law.").
242. Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 707 n.6 (Fed. Cir. 1992) (citations
omitted).
243. See supra Part I.A.
244. See supra Part II.A.3.
245. 363 F.3d 1336 (Fed. Cir. 2004).
246. Id. at 1339 (quoting Monsanto Technology Agreement).
247. Id. at 1342-43.
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licensed product itself, the license "impose [d] a restriction on the use
of the goods made by the licensed product." '248 Acknowledging that
the peculiar facts presented an issue of first impression, the court
concluded that the restriction was valid:
Our case law has not addressed in general terms the status of
such restrictions placed on goods made by, yet not incorporating,
the licensed good under the patent misuse doctrine. However,
the Technology Agreement presents a unique set of facts in
which licensing restrictions on the use of goods produced by the
licensed product are not beyond the scope of the patent grant at
issue: The licensed and patented product (the first-generation
seeds) and the good made by the licensed product (the second-
generation seeds) are nearly identical copies. Thus, given that
we must presume that Monsanto's '435 patent reads on the first-
generation seeds, it also reads on the second-generation seeds.
See '435 patent, col. 165,1. 12 (claiming "[a] seed of a glyphosate-
tolerant plant"). Because the '435 patent would read on all
generations of soybeans produced, we hold that the restrictions
in the Technology Agreement prohibiting the replanting of the
second generation of ROUNDUP READY® soybeans do not
extend Monsanto's rights under the patent statute.249
This chain of reasoning is not self-evidently correct. The key point
underlying the exhaustion doctrine is that a purchaser has acquired
the patented product through authorization by the patentee. In the
usual case, this authorization is through a sale.25° In McFarling,
the defendant farmer did not buy the second-generation seeds,
whose use the court determined to be infringement.251 The second-
generation seeds were nevertheless obtained by the farmer in an
authorized fashion, by planting the seeds to which the farmer did
have a license, as the court acknowledged.252 Consequently, it does
not follow from the fact that the patent at issue arguably covered
the second-generation seeds that the farmer's planting of those
seeds was an infringement.
248. Id.
249. Id. at 1343 (footnote omitted).
250. See SCHECHTER & THOMAS, supra note 184, at 278.
251. See McFarling, 363 F.3d at 1341-43.
252. Id.
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On the other hand, it seems clear that the possibility of replant-
ing posed a very real challenge to Monsanto's patent protection. 2
53
Repair of Mallinckrodt's and Lexmark's products could prolong only
the life of each of those products, but propagation of Monsanto's
seeds could produce an almost unlimited number of copies of the
products. As the court acknowledged, the problem appeared to be a
new one,254 and it deserved serious consideration for the issue it
posed for patent policy. Indeed, Judge Gajarsa of the Federal Circuit
argued in another case that self-replicating products should not be
patentable at all.255
In light of the difficulty of the problem, it is troubling that the
court in McFarling effectively allowed the patentee to solve the
problem through contract. 256 The circumstances can be viewed as
similar to the "making" and "selling" discussions above257 : The first
question one should ask is whether the challenged conduct-the use
of a good produced through acts licensed by the patentee-is in fact
infringement, or whether it should be. If so, then the McFarling
court's decision is perhaps appropriate. This seems an appropriate
question for Congress, however, and not one for the Federal Circuit
to decide in reliance on a restriction imposed by the patentee.
It is also important to note that the Federal Circuit's holding
could have more far-reaching implications. For example, whether
patent law should allow use restrictions not only on the licensed
products themselves-in McFarling, the first-generation seed-but
also on goods produced by permissible uses of the licensed products
-in McFarling, the second-generation seed-may have implications
for the controversial issues of reach-through royalties and patent
claims.258 A reach-through royalty provision is one in which the
253. See id. at 1342-43.
254. Id. at 1343.
255. See SmithKline Beecham Corp. v. Apotex Corp., 365 F.3d 1306, 1331 (Fed. Cir. 2004)
(Gajarsa, J., concurring) ("In short, patent claims drawn broadly enough to encompass
products that spread, appear, and 'reproduce' through natural processes cover subject matter
unpatentable under Section 101-and are therefore invalid.").
256. See McFarling, 363 F.3d at 1343.
257. See supra Parts III.A.1-2.
258. See generally Michael J. Stimson, Damages for Infringement of Research Tool Patents:
The Reasonableness of Reach Through Royalties, 2003 STAN. TECH. L. REV. 3 (discussing the
use of reach-through royalties to encourage patent innovation); Kimberlee A. Stafford,
Comment, Reach-Through Royalties in Biomedical Research Tool Patent Licensing:
Implications of NIH Guidelines on Small Biotechnology Firms, 9 LEWIS & CLARK L. REV. 699
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patentee's royalties are based not only on the licensed product itself,
but on other products produced with the licensed product. 59 A
reach-through claim is one that asserts protection not simply for the
described invention itself but for products developed through its
use. 60 Reach-through royalties and claims have been used most
commonly with chemical and biotechnological research tools.6 1
Although the Federal Circuit has not yet decided a case on the
validity of damages claims based on reach-through patent claims,262
the reasoning of McFarling appears applicable. The nature of the
infringement in McFarling was the violation of the use restriction
on the second-generation seeds,26 ' whereas in a case of reach-
through royalties the infringement would be the failure to pay
royalties on the downstream product.2 4 In the latter case, the
infringement would surely be as significant as that in McFarling.
Additionally, McFarling relied on the claims' coverage of the second-
generation seeds to find that the infringement claim was within
Monsanto's patent rights.265 If reach-through claims covered the
downstream product on which royalties were to be paid, the same
result presumably would apply.
It is possible, of course, that the Federal Circuit might not follow
this course should such a case arise. For example, the court might
say that the critical point in McFarling was that the claims covered
both the first-generation and second-generation seeds. There is
support for such a reading in the court's observation that the claims
(2005) (discussing the controversy between the government and the biomedical field due to
reach-through royalty provisions); PIERRE VtRON & OLMIER MOUSSA, PROTECTING THE
RESULTS OF FUTURE RESEARCH: REACH-THROUGH CLAIMS IN EUROPEAN AND U.S. LAWS,
http://www.veron.com/files/publications/Protecting-the-results_of_future_ research.pdf
(discussing the principles of reach-through claims).
259. See VPRON & MOUSSA, supra note 258, at 13.
260. See id. at 2-3.
261. See id.
262. The court has held in one case that claims for methods of using unknown chemical
compounds that could perhaps be identified using the techniques disclosed were invalid for
lack of a sufficient written description. See Univ. of Rochester v. G.D. Searle & Co., 358 F.3d
916 (Fed. Cir. 2004). Under the court's reasoning in that case, however, other reach-through
claims could be valid. A federal district court has held that reach-through licensing was not
patent misuse, at least where alternative licensing techniques were also available. Bayer AG
v. Housey Pharms., Inc., 228 F. Supp. 2d 467, 470-74 (D. Del. 2002).
263. Monsanto Co. v. McFarling, 363 F.3d 1336, 1339-41 (Fed. Cir. 2004).
264. See generally Stimson, supra note 258.
265. See McFarling, 363 F.3d at 1339.
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"would read on all generations of soybeans produced. 266 Why that
fact should be of legal significance is not clear, however, if the
patentee has claims covering both products. In any event, the point
is not that McFarling necessarily decided the reach-through issues;
the point is that the court's adoption of an ad hoc solution to the
McFarling problem may have unintended consequences in other
sorts of cases, especially when the court has not clearly defined
the boundaries of its solution. For that reason, a more carefully
considered approach would have been preferable.
B. Restrictions on Downstream Purchasers
As described above, both the Supreme Court and Europe's TTBER
have distinguished between use restrictions imposed on manufac-
turing licensees and those imposed on the ultimate purchasers of
patented products.267 A variety of reasons support this distinction.268
Most fundamentally, several of the field-of-use cases discussed
here involved patent infringement suits against parties who had not
themselves entered into the license contract in which the use
restriction was included.269 As a result, those parties would not
necessarily know of the restrictions at issue, and the cost of
obtaining such information could be significant, raising the cost of
product distribution.27 °
Untroubled, U.S. courts take the view, derived from the Federal
Circuit, that when a use restriction is violated, no valid license of
the patent rights exists.27' Consequently, the infringement suit
against the downstream purchaser is equivalent to one against the
266. See id. at 1343.
267. See supra Parts LA, I.D.
268. The discussion here focuses on concerns at the level of legal doctrine. These sorts of
restrictions also present more fundamental, economy-wide concerns. See Peter C. Carstensen,
The New Feudalism: Post Sale Patent Licensing and the Destruction of the Dynamic Economy
22-31 (2006) (unpublished manuscript, on file with author).
269. See supra Part II.B-C.
270. See James B. Kobak, Jr., Exhaustion of Intellectual Property Rights and International
Trade, 5 GLOBAL ECON. J. 1, 1 (2005) ("The theory behind the [exhaustion] doctrine is that it
enables the IP Owner to receive one fair reward for surrendering its right to withhold a
product from the market but thereafter permits free disposition and movement of chattels;
in this way, it is thought, IP rights will not unduly disrupt a modern and efficient system of
distribution....").
271. See supra Part II.B.2.
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purchaser of an illegally manufactured product, and knowledge of
infringement is not central to patent law.272
Even some of the courts that have been willing to enforce shrink-
wrap licenses have been unwilling to allow the contract to create
infringement suits against nonparties. For example, in ProCD, Inc.
v. Zeidenberg,2 73 one of the most prominent shrink-wrap cases,
Judge Easterbrook seemed to suggest that if the defendant had
passed the software on to another, downstream user, no infringe-
ment suit could have been brought against that downstream user:
A copyright is a right against the world. Contracts, by contrast,
generally affect only their parties; strangers may do as they
please, so contracts do not create "exclusive rights." Someone
who found a copy of [the copyrighted, shrink wrap-licensed
software] on the street would not be affected by the shrinkwrap
license-though the federal copyright laws of their own force
would limit the finder's ability to copy or transmit the applica-
274tion program.
Of course, the parties in the present field-of-use cases may not be
equivalent to someone finding an invention on the street. They
might have been on notice of the patentee's efforts to impose
restrictions on the use of the inventions. In fact, that was the theory
on which the Supreme Court, in General Talking Pictures, allowed
imposition of liability on a downstream purchaser. 5 In that case,
however, the violation of the terms of the license was by the
manufacturing licensee, not the downstream purchaser, 76 and it is
not clear that the Supreme Court would have allowed a restriction
that applied only to that downstream purchaser.277
The problem posed here is emphasized by the fact that the first
buyers in several of these field-of-use cases did not violate the
license terms.278 For example, the stores in which the toner car-
272. See id.
273. 86 F.3d 1447 (7th Cir. 1996).
274. Id. at 1454.
275. Gen. Talking Pictures Corp. v. W. Elec. Co., 305 U.S. 124, 126 (1938).
276. See id. at 125-26.
277. Indeed, Justice Black would not have allowed liability on the purchaser even under
the facts in the case. See id. at 132-33 (Black, J., dissenting).
278. See supra Part II.A.
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tridges in Lexmark were sold did not refill the cartridges,279 nor did
the grain sellers in McFarling and Scruggs replant seeds.2"
Consequently, in those cases, valid sales occurred in compliance
with the license terms, which would generally bring the exhaustion
doctrine into play. By allowing infringement suits against down-
stream purchasers who were the first to fail to comply with the
license terms, the courts have effectively allowed patent rights to be
revived after a first sale that should have exhausted those rights.
The preceding sections have shown how the lower courts'
treatment of field-of-use licenses have allowed patentees to
transform permissible repair and resale into patent infringement.
Even where the proper scope of infringement is not so clear, as with
self-replicating products and restrictions on downstream purchases,
the courts' reliance on use restrictions has prevented careful
analysis of the policy issues. None of this shows, though, that there
are not legitimate goals for use licensing. As the next Part shows,
those goals can be achieved without unnecessarily expanding the
scope of patent infringement.
IV. THE BENEFITS OF USE LICENSING
The examples of field-of-use licensing in the cases discussed
here" ' appear to be directed at two goals. First, such licenses serve
the basic purpose of intellectual property protection itself, which is
the prevention of free riding on the creator's inventive efforts.2"2
This is most evident in the Monsanto cases, in which the use
restrictions presumably were intended to prevent reproduction of
the patented seeds by farmers.283 Second, use licenses further
patentee-controlled price discrimination. Several of the field-of-use
licenses in these cases did not so much discriminate among different
uses of the inventions as discriminate based on the number of uses
the purchasers made of the patented products.2" The nature of this
279. See supra Part II.A.1.
280. See supra Part II.A.3.
281. See supra Part II.A.
282. See ROGER E. SCHECHTER & JOHN R. THOMAS, INTELLECrUAL PROPERTY: THE LAW OF
COPYRIGHTS, PATENTS, AND TRADEMARKS § 13.4.1 (2003).
283. See supra Part II.A.3.
284. See supra Part II.A.
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limitation was quite explicit in the "single use only" restriction of
Mallinckrodt,285 but it was also the effect of the no-refilling restric-
tion of Lexmark.8 6 In addition, the restriction in Ottawa Plant Food
allowed Pioneer to price discriminate among different geographical
territories.8 7
This Part questions the application of field-of-use licenses for
these two goals. Although the goals may be valid, it is unclear that
use licensing serves them or, in any event, that it does so in the
least restrictive way. In fact, solutions are available to patentees
that address each of these two problems more specifically. First, if
a patentee engages in inventive activity in a secondary market and
seeks to prevent free riding on that activity, it can obtain a patent
on that specific activity. Second, if a patentee finds that potential
purchasers are unable or unwilling to pay up front the requested
price for its patented product, but the purchasers will use that
product several times, the patentee can establish by contract-but
not by patent law-a long-term, or even per-use, financing arrange-
ment.
None of this is to say that there are not other legitimate applica-
tions for field-of-use licensing. Contractual provisions that truly
restrict licensees to particular fields of use can serve the beneficial
purposes often attributed to use licensing.2"' But to serve those
purposes a restriction should, as the TTBER Guidelines state, "be
defined objectively by reference to identified and meaningful
technical characteristics of the licensed product., 219 If U.S. courts
confined their lenient treatment of use licensing to restrictions that
met that test,290 the general approval of the restrictions could be
appropriate.29' The focus of this Article is on restrictions that do not
285. Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 701 (Fed. Cir. 1992).
286. See supra Part II.A.1.
287. See supra Part II.A.2.
288. See supra note 1.
289. TTBER Guidelines, supra note 1, 180. It might also be legitimate for a field-of-use
restriction to be defined by reference to economic markets. In General Talking Pictures, for
example, the amplifiers were apparently the same whether they were used in home or
commercial applications. But those applications presumably had very different market
characteristics, see supra notes 2-3 and accompanying text.
290. As noted above, the courts have not adopted a definition of a field-of-use license. See
supra Parts I.A-B, II.A.
291. Another approach would be to enumerate specifically the circumstances in which a
violation of a use license would be patent infringement. A similar approach is taken by the
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meet that test, and the sections below show that the legitimate
goals of such restrictions can be accomplished in other ways.
A. Free Riding
1. "Free Riding" in Downstream Markets
A patentee might argue that any competitor in a secondary
market that derives from the patented product is, by definition, free
riding on that product. In fact, Lexmark's attorney has made this
exact argument with respect to the refilling of its toner cartridges.292
Moreover, this argument appears to receive some support from a
statement in the U.S. antitrust agencies' Antitrust Guidelines for
the Licensing of Intellectual Property: "The Agencies will not
require the owner of intellectual property to create competition in
its own technology." '293
Competition in a secondary market, however, is not necessarily
competition in the technology of the patentee. The competition in
the secondary market may take place with respect to features or
services that are independent of the patented technology. The
European Community in trademark law:
The proprietor of a Community trade mark may invoke the rights conferred by
that trade mark against a licensee who contravenes any provision in his
licensing contract with regard to its duration, the form covered by the
registration in which the trade mark may be used, the scope of the goods or
services for which the licence is granted, the territory in which the trade mark
may be affixed, or the quality of the goods manufactured or of the services
provided by the licensee.
Council Regulation (EC) No 40/94 of 20 December 1993 on the Community trade mark, art.
22.2. (For this point I am indebted to Professor Annette Kur of the Max Planck Institute for
Intellectual Property in Munich.)
It is important to note that under this section none of the types of license violations that
a trademark owner could challenge as infringement would constitute permissible conduct in
the absence of a license. Instead, each enumerated violation is a typical limit on the scope of
a license. Furthermore, the reference to a provision regarding the "scope of the goods or
services for which the licence is granted" describes a provision that is genuinely related to the
field of use of the intellectual property. Nevertheless, the employment of a list of possible
infringement violations would allow the application of use restrictions to extend beyond
technically defined fields of use without resulting in the blanket approvals of recent U.S.
decisions.
292. Personal Communication with Richard B. Ulmer, Jr., Counsel to Lexmark
International, Inc., at Fordham Law School, New York, N.Y. (Nov. 18, 2005).
293. IP GUIDELINES, supra note 1, § 3.1.
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question, then, is whether the patentee is entitled to restrict
competition in those downstream markets regardless of whether the
particular nature of that competition relates to the patented
technology.29 4 In this respect, Mallinckrodt's test for the validity of
a use restriction-asking whether the restriction "relates to subject
matter within the scope of the patent claims"295 -may be read to
limit the patentee's power to the restriction of competition that is
related to the patentee's technology, as distinguished from the
patentee's product in general. Any use restrictions that go beyond
that limit should be impermissible.
The Supreme Court's decision in Eastman Kodak Co. v. Image
Technical Services, Inc. directly supports this view.296 In that case,
Kodak denied independent servicers of its copiers access to copier
parts, some of which were patented. 297 Kodak argued that the
servicers were free riding on its investments in designing the
copiers."' Kodak did not argue, however, that the servicers were
directly free riding on its copier investments, because the owners of
the copiers purchased them from Kodak. Furthermore, Kodak did
not argue that the servicers were directly free riding in the parts
market, because they sought to buy the parts from Kodak. Instead,
Kodak argued that the servicers were indirectly free riding because,
as the Court described the argument, "they have failed to enter the
equipment and parts markets.""29 Rejecting this argument, the
Court stated that "[t]his understanding of free riding has no support
in our case law."300 Kodak had a valid free riding argument if the
independent servicers were free riding on Kodak's investments in
the services market, but simply competing in the secondary market
did not constitute free riding on the primary market.
Drawing another European analogy, a similar approach is
reflected in the European Commission's motor vehicle block
exemption regulation. The regulation exempts from antitrust
294. See generally Mark R. Patterson, When Is Property Intellectual? The Leveraging
Problem, 73 S. CAL. L. REV. 1133 (2000) (providing a broader discussion of this general issue).
295. Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 708 (Fed. Cir. 1992); see also supra
notes 60-62 and accompanying text.
296. See 504 U.S. 451 (1992).
297. Id. at 458.
298. Id. at 483.
299. Id. at 485.
300. Id.
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liability certain conduct by automobile manufacturers. °1 It excludes
from the exemption, however, and thus retains liability for, a refusal
by a manufacturer to provide either spare parts or technical
information to independent operators that provide aftermarket
repair or maintenance.0 2 Thus, the exemption views "the market for
repair and maintenance services"30 3 as one that is economically
independent of the market for automobiles. Although the aftermar-
ket is dependent on parts and information from the primary market,
the use of those parts and that information is not impermissible free
riding.
30 4
In fact, the aftermarket activities against which the patentees in
the field-of-use cases claim protection are often unrelated to the
patentees' inventive activities.3 5 That is most clear in Ottawa Plant
Food, where the patent at issue was for corn seeds, yet the defen-
dants' activities were as resellers of those seeds. 30 The patentee was
therefore using its patent on seeds to restrain competition in seed
distribution, an area in which the patentee had produced no
evidence of innovation. The Lexmark inventions were also unrelated
to the activity of the defendant in that case.30 7 Although Lexmark
had a variety of patents on various aspects of toner cartridge
technology, none of them was on an invention related to the
refilling, or even the filling, of the cartridges.3 8 Hence, it does not
appear that the refillers could be viewed as free riding on Lexmark's
inventions; instead, the refillers had created a secondary market in
which Lexmark's inventions played no role. In these instances,
characterizing downstream users as "free riding" is misleading.
301. See Commission Regulation (EC) No. 1400/2002, On the Application of Article 81(3)
of the Treaty to Categories of Vertical Agreements and Concerted Practices in the Motor
Vehicle Sector, 2002 O.J. (L 203/30) art. 2.
302. See id. at art. 4.
303. Id. at art. 1(26).
304. See generally Commission Regulation (EC) No. 1400/2002, On the Application of
Article 81(3) of the Treaty to Categories of Vertical Agreements and Concerted Practices in
the Motor Vehicle Sector, 2002 O.J. (L 203/30).
305. A significant exception is found in the Monsanto cases. See infra Part IV.B.3.
306. See supra Part II.A.2.
307. See supra Part II.A.1.
308. See id.
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2. Patents Related to the Use at Issue
As I have argued elsewhere," 9 this analysis indicates that the
free-riding argument is appropriate when the patentee's inventive
activity relates to the secondary market. In Kodak, for example, if
the independent service organizations had been using Kodak
inventions that made servicing of the machines easier, one could
reasonably have argued that Kodak was entitled to prevent such
use. Consequently, it is important to examine the actual claims of
the patents at issue in these cases, a task in which the courts
seldom engage.
If a patentee believes that the use to which a purchaser will put
the patentee's invention will infringe upon the patentee's rights, the
patentee is always free to seek a patent on that use. For example,
if Lexmark believed that it created an innovation that entitled it to
exclude others from refilling its toner cartridges-such as an
improved filling system-it could have described that innovation
and sought patent protection for it. It could have done so by
claiming either the system itself or the process of refilling that it
made possible. And in Ottawa Plant Food, if Pioneer created some
innovation in the seed distribution system from which it sought to
exclude the defendant, it could have sought patent protection for the
new system. In fact, this is the approach that one would expect a
patentee to take to address free riding on its inventive effort."' 0 If
the patentee has not produced any innovation related to the uses it
seeks to prohibit, then the patentee should not be permitted to
restrict those uses.
It is true that patent law allows the patentee to exclude others
from "using" its invention, whether the patentee seeks protection on
a particular feature of the invention or not. The "uses" that
patentees have sought to prevent in the recent field-of-use cases,
however, were not really "uses" but instances of repairing and
reselling the invention. 1' That is, patentees restricted "uses" that
309. See supra note 294 and accompanying text.
310. Justice Black, for example, made the same point in Aro I: "Of course, if novelty should
inhere in one of the parts as well as in the whole, then that novel 'heart' or 'core' can be
separately patented and separately protected." Aro Mfg. Co. v. Convertible Top Replacement
Co. (Aro 1), 365 U.S. 336, 361 (1961) (Black, J., concurring).
311. See supra Parts III.A.1-2.
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patent law previously determined the patentee could not restrict. To
bring those uses back within the scope of patent law, the patentee
should be required to demonstrate its specific entitlement to them
via a specific patent.
Mallinckrodt illustrates how far patentees can be from meeting
this requirement. The inventions in Mallinckrodt included aerosol
nebulizers, 312 a manifold for transmitting the aerosol to a patient,313
and the combination of nebulizer, manifold, and shielding box. 14
The district court in Mallinckrodt pointed out that the defendant,
Medipart, did not even disassemble the nebulizer-manifold combina-
tions that it received from hospitals, but simply sent them to be
radiation-sterilized and then packaged with new unpatented
components before returning them to the hospitals. 35 The district
court also made clear that the radiation sterilization-the only "use"
to which Medipart put the patented inventions-was not the subject
of any of the patents at issue: "Neither the specifications nor the
claims of any of the patents in suit state that the nebulizer and/or
manifold are for single use only or must be disposed of. Nor do they
claim that either the manifold or the nebulizer are clean or disin-
fected.,, 316 Thus, Mallinckrodt apparently lacked patent protection
related to the "use" to which Medipart put the Mallinckrodt
inventions.1 7
In this respect, Mallinckrodt may be contrasted with another
Federal Circuit case, Jazz Photo Corp. v. International Trade
312. U.S. Patent No. 4,456,179 (fied June 26, 1984); U.S. Patent No. 4,251,033 (filed Feb.
17, 1981); U.S. Patent No. 4,116,387 (filed Sept. 26, 1978).
313. U.S. Patent No. 4,529,003 (filed July 16, 1985).
314. U.S. Patent No. 4,782,828 (filed Nov. 8, 1988).
315. See Mallinckrodt, Inc. v. Medipart, Inc., No. 89-C-4524, 1990 U.S. Dist. LEXIS 1974,
at *2-4 (N.D. II. Feb. 16, 1990), rev'd, 976 F.2d 700 (Fed. Cir. 1992).
316. Id. at *2.
317. Actually, one of the patents that Mallinckrodt asserted in the case describes the
invention as designed in part to facilitate easier disposal of the used radioactive nebulizer. See
Mallinckrodt, 976 F.2d at 702. Although the alleged infringer did not engage in disposal of the
nebulizer, but rather sterilized it for reuse, id., one could perhaps view those two practices as
competitors in the post-use nebulizer servicing market. Medipart might argue in response
that as an alternative to disposal, reusers cannot free ride on features of the invention
designed to facilitate disposal. But it is possible that those same features make transportation
of the nebulizer to Medipart more feasible, which could be viewed as free riding. This issue
need not be argued extensively here, but this is the sort of inquiry that should be conducted
to determine whether a prohibited use "relates to subject matter within the scope of the
patent claims." Id. at 708.
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Commission.318 The Fuji patents at issue in Jazz Photo related to
single-use cameras that Jazz Photo had refurbished by putting new
film in the used camera casings, or 'lens-fitted film packages"
(LFFPs).319 Perhaps questionably, the court concluded that a multi-
step process for replacement of the film constituted permissible
repair rather than impermissible reconstruction.320 Putting aside
possible shortcomings in the repair conclusion, however, one of the
patents at issue included claims directed specifically at the loading
of film into the cameras.321 The district court specifically found these
claims were infringed, a conclusion reversed by the Federal Circuit
on the ground that the "defense of repair is applicable to process
claims, as well as to apparatus claims, when the patented process
was used in the United States and the patent right has been
exhausted for the articles produced thereby.3 22
It is unclear that this conclusion is correct. The court stated that
"[w]hen a patentee sells a device without condition, it parts with the
right to enforce any patent that the parties might reasonably have
contemplated would interfere with the use of the purchased
device. 323 But this principle need not require that the exhaustion
doctrine apply to all processes that could be used to produce a
product sold. For example, it seems unlikely that buyers of single-
use cameras expect to be able to refill them with new film. The
318. 264 F.3d 1094 (Fed. Cir. 2001).
319. Id. at 1099-100.
320. Id. at 1106-07. The court's conclusion seems questionable because the amount of work
performed in the refurbishment was considerable, both quantitatively and qualitatively:
We conclude that for used cameras whose first sale was in the United States
with the patentee's authorization, and for which the respondents permitted
verification of their representations that their activities were limited to the steps
of (1) removing the cardboard cover, (2) cutting open the plastic casing, (3)
inserting new film and a container to receive the film, (4) replacing the winding
wheel for certain cameras, (5) replacing the battery for flash cameras, (6)
resetting the counter, (7) resealing the outer case, and (8) adding a new
cardboard cover, the totality of these procedures does not satisfy the standards
required by precedent for prohibited reconstruction; precedent requires, as we
shall discuss, that the described activities be deemed to be permissible repair.
Id. at 1098-99. It was not clear whether all the respondents had used this process. For those
that had not, or for which the process used was unclear, the court let stand the I.T.C.'s
reconstruction decision. Id. at 1110-11.
321. See id. at 1108-09 (citing U.S. Patent No. 4,972,649) (filed Nov. 27, 1990).
322. Id. at 1108 (citation omitted).
323. Id. at 1108-09 (citing Hewlett-Packard Co. v. Repeat-o-Type Stencil Mfg. Corp., 123
F.3d 1445, 1455 (Fed. Cir. 1997)).
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court's treatment, however, correctly suggests that it is not actual
expectations that determine exhaustion but the contours of the
repair-reconstruction dichotomy.324
Even so, the court appears to have misstated the repair-recon-
struction rule. The courts generally have indicated that if the act of
repair involves the use of a patented replacement part, the repair is
impermissible. For example, in Aro I, the Supreme Court character-
ized the question as "whether the replacement of an unpatented
part, in a patented combination, that has worn out, been broken or
otherwise spent, is permissible 'repair' or infringing 'reconstruc-
tion."'" 25 In the same way that the replacement of a patented
replacement part would overstep the repair doctrine (unless the part
were obtained from the patentee), use of a patented repair process
also seems impermissible.
Many repair processes, however, may not be patentable because
they would be obvious. Indeed, the process claims in Jazz Photo
make the obviousness challenges in that case seem warranted:
In the method of claim 1, the film is wound from the cartridge
onto a roll in a darkroom; both the film roll and the empty
cartridge are then inserted into the LFFP and the casing is
sealed. In the method of claim 9, a film cartridge is placed in the
LFFP and the film leader is attached to a spool in the unexposed
film chamber; the casing is then sealed, and an external
apparatus winds the film into the unexposed film chamber.32
Yet in Jazz Photo, the administrative law judge, the Commission,
and the court all concluded that the infringers' burden of showing
invalidity had not been met.32 7 Given that conclusion-assuming
that the film-loading method was in fact new and nonobvious-it is
not clear that repairers like Jazz Photo should be able to use the
process without permission from the patentee. This requirement
would not prevent repair of the products in general, but would
prevent only use of that particular process for repair. In sum, just
as new uses of unpatented products are patentable, so there should
324. See id. at 1105.
325. Aro Mfg. Co. v. Convertible Top Replacement Co. (Aro 1), 365 U.S. 336, 342 (1961)
(emphasis added).
326. Jazz Photo, 264 F.3d at 1108 (citing U.S. Patent No. 4,972,649) (filed Nov. 27, 1990).
327. Id. at 1101-02.
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be no obstacle to patenting a new method of repairing a patented
product.
B. Price Discrimination and Financing
The price discrimination that results from the use licensing in
these cases may serve either of two purposes. First, it may increase
the patentee's profits, as price discrimination generally does.
Whether this goal is valid is not entirely clear, especially when the
price discrimination is accomplished through arrangements af-
fecting distinct markets related to the patented product. Second, the
price discrimination may provide a means for buyers to pay for the
patented products over the life of the product, either with or without
increasing the patentee's profits. In this context, although the
advantages of such a contractual arrangement are evident, they
need not be enforceable through patent law.
1. Price Discrimination in Related Markets
The permissible scope of price discrimination in patented
products is not entirely clear. In the United States, it is generally
accepted that "there is no antitrust prohibition against a patent
owner's using price discrimination to maximize his income from the
patent."32 Nevertheless, this statement can be interpreted too
broadly. Tying arrangements are often used to price discriminate,
yet use of them is impermissible if the patentee has market
power. 2 9 Furthermore, where the exhaustion doctrine has been
implicated, the Supreme Court has rejected other patent infringe-
ment suits that facilitated price discrimination even when no
unpatented products were involved. For example, the Court has not
allowed patentees to enforce territorial restrictions after the first
sale of the product. °
328. USM Corp. v. SPS Techs., Inc., 694 F.2d 505, 512 (7th Cir. 1982).
329. See 35 U.S.C. § 271(d)(5) (2006); Jefferson Parish Hosp. Dist. No. 2 v. Hyde, 466 U.S.
2, 12-14 (1984).
330. Several early Supreme Court cases concerned purchases of patented goods within the
territory of one licensee and resales of those goods in the territory of another licensee. The
goal of the geographic allocation of territories was presumably price discrimination (though
it could have been the prevention of free riding, which is discussed above), yet the Supreme
Court repeatedly rejected infringement suits in this context. See, e.g., Keeler v. Standard
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Although the courts have not clarified this difference in the
treatment of alternative price discrimination techniques, one can
perhaps conclude that there is no prohibition on price discrimina-
tion that is accomplished directly by charging different prices to
different purchasers; on the other hand, a price discrimination goal
will not save an otherwise impermissible restriction, such as tying.
If that is the correct reading of the cases, then the use restrictions
at issue in this Article seem unlikely to be saved by their
enablement of price discrimination by patentees. Because they
enable price discrimination by effectively redefining the limits of
infringement,33' they go well beyond the direct forms of price
discrimination that the Supreme Court has approved.
Moreover, the effect of these restrictions is to use the patent to
restrain competition in a second market, much as with tying
restrictions. This effect is most evident in Ottawa, where the
restriction restrained competition in the downstream dealer market
in which the defendant resold the seed.332 In both Mallinckrodt and
Lexmark, however, the restrictions also restrained competition, or
potential competition, in downstream markets for reconditioning
services.33 Although there was no formal tie in these cases, the
similar effect of the use restrictions suggests that the mere fact that
the restrictions allow price discrimination is not sufficient to justify
them.
2. Price Discrimination Through Contract
Importantly, though, by repairing the patented products, the
alleged infringers in the reconditioning cases prevented the
patentees from making additional sales of the products. This
prevention of additional sales made it more difficult for the
Folding Bed Co., 157 U.S. 659, 672 (1895); Adams v. Burke, 84 U.S. (17 Wall.) 453, 456-57
(1873).
The Supreme Court has permitted patentees to impose pricing restrictions on
manufacturing licensees where necessary to protect the patentee's profits, United States v.
Gen. Elec. Co., 272 U.S. 476, 491 (1926), but it has condemned resale price maintenance for
patented goods in other contexts. See, e.g., Straus v. Victor Talking Mach. Co., 243 U.S. 490,
501 (1917).
331. See supra Part ILA.
332. See supra Part II.A.2.
333. See supra Parts I.B, II.A.1.
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patentees to price discriminate based on intensity of use. As a
result, the overall financial return of the patentees might have
decreased, and lower returns possibly could lessen patentees'
incentives for invention.
It is hard to see, however, why this result should be viewed as
problematic in itself."4 A patent does not entitle the patentee to
profits,335 or even to a particular pricing technique, but only to
exclusion of its competitors, and that exclusion is limited by the
other rules of patent and competition law. A patentee therefore
cannot defend a tying arrangement by arguing that it needs to use
the tying arrangement to keep up its profits.33 In any event, it is
unclear for most of these inventions that the patentee would be
unable to price them profitably, even if reuse of the products were
not possible. Patentees sell many reusable products without the
sorts of license restrictions at issue in these field-of-use cases and,
except in exceptional cases,3 7 there is no indication that it would be
impossible to price the products at issue in the cases discussed in
this Article in such a way as to make their sales profitable.
Moreover, even if a single sale would be difficult, there is no
obstacle to a patentee's use of a long-term financing arrangement or
some other sort of contractual solution. Specifically, a patentee
could achieve through contract an effect identical to the use
restrictions involved in the cases discussed above, but it would be
unable to enforce the restriction through patent law. The absence of
patent protection would mean that patentees would be limited to
contract remedies for violations of the contracts, but those remedies
334. See Stern, Post-Sale, supra note 25, at 11-12 ('Without getting bogged down in the
rights and wrongs of each side's possible arguments, one may conclude that presence of a
wealth transfer effect need not be outcome-determinative."); see also id. at 29-31 (discussing
the wealth transfer argument).
335. See In re Kirk, 376 F.2d 936, 963 (C.C.P.A. 1967) (Rich, J., dissenting) ('The basic
proposition to patentees is: if your invention has market value and if you can exploit it with
profit, that profit will be secured to the extent that you may have the right to exclude others
from exploiting your invention. Whether that right has value is, of course, entirely dependent
on whether the invention has value." (emphasis added)).
336. The tying of unpatented to patented products remains per se illegal if the patentee has
power in the market for the patented product. See Ill. Tool Works, Inc. v. Indep. Ink, Inc., 547
U.S. 28, 36-37 (2006).
337. See infra Part IV.B.3.
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do not appear to be insufficient to protect the patentees' legitimate
interests in these areas (again, except in exceptional cases38).
The boundaries on the patentees' contractual interests would be
policed by the limits placed on contractual restraints by competition
law, but that is entirely appropriate. The restrictions discussed
above generally involve restrictions on downstream markets, and it
is competition law, not patent law, that has developed a body of
doctrine to police market relationships.339 Moreover, competition
law, unlike patent law, can weigh the benefits to patentees of
340contractual restrictions against the costs to consumers.
This approach is more consistent with the U.S. antitrust agencies'
approach than is Mallinckrodt's. The IP Guidelines state that the
agencies generally apply the rule of reason, rather than the per se
rule, to licensing arrangements. 31' Although the Federal Circuit in
338. See id.
339. Restraints involving different market levels are vertical restraints, and are generally
judged under the rule of reason. See generally Leegin Creative Leather Prods., Inc. v. PSKS,
Inc., 127 S. Ct. 2705, at *38-39 (2007); Continental T.V., Inc. v. GTE Sylvania, Inc., 433 U.S.
36, 54-57 (1977).
340. Antitrust law's rule of reason requires a balance of procompetitive and anticompetitive
effects, but a patent infringement suit requires no showing that the incentive benefits of the
patent protection at issue outweigh the costs of the statutory monopoly.
This point applies even more strongly because the patentee will not necessarily know to
what use its invention will be put. In Mallinckrodt, the "single use only" restriction probably
was imposed in part because of the health and safety concerns raised by the reuse of medical
equipment. See Mallinckrodt Inc. v. Medipart Inc., 976 F.2d 700, 708-09 (Fed. Cir. 1992)
(citing cases that relied on safety concerns). But the patentee will not generally know whether
such concerns exist for a particular purchaser.
For example, the author of this Article recently purchased a kit for cleaning the print heads
of an inkjet printer, and the kit included a syringe for use with the cleaning fluid. The syringe,
like the nebulizer in Mallinckrodt, came with a "single use only" restriction. Despite that
restriction, the manufacturer presumably had no objection to the reuse of the syringe in a
non-medical application. Nevertheless, under Mallinckrodt, the reuse of the syringe, if
determined to be "within the patent grant," would be patent infringement, and there would
be no room for an argument that the restriction was unreasonable as applied to the author
in these circumstances.
In fact, there was no indication that this particular syringe was patented. That only
emphasizes, however, the arbitrary nature of the current treatment of use licensing. If the
syringe is unpatented, the manufacturer can probably not enforce its restriction, because the
notice does not create a valid contract. See supra Part II.B.1. It is unlikely that any applicable
health regulations would afford the manufacturer a private right of action. But if the syringe
is patented, the manufacturer could enforce its restriction through a suit for patent
infringement, regardless of the nature of its invention and its relationship to use of the
product.
341. See IP GUIDELINES, supra note 1, at 16.
WILLIAM AND MARY LAW REVIEW
Mallinckrodt held out the possibility that the rule of reason would
apply to field-of-use licenses that are not within the patent grant, its
broad interpretation of the range of licenses that are within the
patent grant effectively eliminated that prospect.3 42 As a result, the
Mallinckrodt approach has resulted in per se legality for field-of-use
restrictions, and the recent Scruggs case apparently went further by
explicitly adopting a rule of per se legality.3 43 Consequently, the
current approach circumvents the competitive analysis called for by
the IP Guidelines, instead of providing a considered alternative.
Confining the patentee's remedies to those available in contract
law also receives some conceptual support from the scope of the EC's
TTBER. As described above, 44 most of the field-of-use restrictions
discussed in this Article would not be treated as technology
transfers under the TTBER because, in the sense required by the
TTBER, the restrictions are not really uses of the patentee's
technology at all. The approach of the TTBER is similar to that of
the U.S. Supreme Court, as interpreted by the district court in
Mallinckrodt,345 which would have given the restriction in that case
no special protection from patent law. Although the Federal Circuit
rejected this approach on appeal in Mallinckrodt,3 46 the better
approach would limit the domain of these restrictions to contract
law.
3. Exceptional Cases Requiring Patent Protection
The seeds and replanting restrictions at issue in McFarling47 and
Scruggs34 might be an exception to the sufficiency of contract law.
Both cases imposed restrictions on the ability of farmers to save
second-generation seed harvested from planting the first-generation
patented seed. 9 The patentee's concern seems valid, in that seeds
do not just reproduce themselves once but multiply. In theory,
therefore, the sale of one seed could enable the purchaser to produce
342. See supra Part II.A.
343. See supra Part II.A.3.
344. See supra Part I.D.
345. See supra text accompanying notes 43-44.
346. Mallinckrodt, Inc. v. Medipart Inc., 976 F.2d 700, 708 (Fed. Cir. 1992).
347. Monsanto Co. v. McFarling, 363 F.3d 1336 (Fed. Cir. 2004).
348. Monsanto Co. v. Scruggs, 459 F.3d 1328 (Fed. Cir. 2006).
349. See supra Part II.A.3.
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an unlimited number of additional seeds. This poses a unique
problem for the patentee, and one that is not easily solved by
contract.
Yet the very uniqueness of the problem suggests that it should
not be addressed by a general rule allowing patentees to define the
scope of infringement by contract. Instead, it seems that if these
inventions pose a particular incentive problem, the law should
address that specific problem and tailor a solution addressed to it.
In this case, congressional action would be the preferable choice.5 °
In the recent past, Congress has modified patent laws to respond to
the problems of particular technologies, 351 and similar action may be
desirable here.
In the meantime, however, the courts may feel called upon to
develop their own solutions. Arguably, this is what the district court
in Scruggs attempted to accomplish with its initial decision on a
preliminary injunction, in which it allowed the use restriction
simply because it "was the only reasonable alternative available to
it if it hoped to garner a reasonable return on its sizeable invest-
ment while making the technology available for commercial use at
a reasonable price to consumers." '352 Aside from the courts, commen-
tators such as Richard Stern have proposed a similar approach as
a general replacement for Mallinckrodt."3
The problem is that it is difficult to evaluate claims that a
particular licensing approach is essential to "garner a reasonable
return" '354 on the patentee's inventive activity. The difficulty seems
sufficient to counsel against this approach as a general solution,
especially given the alternatives available to patentees. For
example, although the Monsanto cases are offered here as an
example of when such a licensing approach may be necessary,
350. Cf. Stern, Post-Sale, supra note 25, at 36 ("Even assuming (as we may for the moment)
that the Mallinckrodt doctrine is wiser policy than the exhaustion doctrine, it is troublesome
that the determination and corrective action here were judicial rather than legislative.").
351. See Biotechnology Process Patent Revision, Pub. L. No. 104-41, 109 Stat. 351 (codified
as amended at 35 U.S.C. § 103(b) (2006)) (updating biotechnology patent process); 35 U.S.C.
§ 273 (2006) (allowing defense to patent infringement for use that pre-dated patent filing by
one year).
352. Scruggs, 249 F. Supp. 2d at 753; see also supra text accompanying note 137.
353. See Stern, Post-Sale, supra note 25, at 36-39.
354. Scruggs, 249 F. Supp. 2d at 753.
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Monsanto in fact uses a different licensing technique that allows
seed saving in countries other than the United States. 5'
Of course, it is possible that Monsanto can do so precisely because
of the returns it receives by prohibiting seed saving in the United
States, but the information that would allow evaluation of that
possibility, if it exists at all, is in the possession of Monsanto. Hence,
even if this approach were adopted for exceptional cases, the
placement of the burdens of production and persuasion in such cases
would be critical. The U.S. patent system offers little precedent for
such an ad hoc evaluation of economic effects, but again there is a
European analog. Traditionally, the European courts vigorously
defended exhaustion principles, at least where territorial restric-
tions and the free movement of goods were at issue.356 In the
GlaxoSmithKline judgment of September 2006,3s7 however, the
Court of First Instance upheld GlaxoSmithKline's use of contractual
price differentials to discourage parallel trade in pharmaceuticals.35
The court held that the Commission failed to give sufficient
consideration to efficiency gains, in the form of innovation, that
could be made possible by the national partitioning of markets.359
For present purposes, the key point from GlaxoSmithKline is that
it calls for an explicit balancing of innovation incentives against the
usual patent exhaustion principles. Although the court did not make
355. In other countries, Monsanto allows seed saving, but requires farmers to pay a
technology fee every year. Reply Brief of Appellants at 21-22, Monsanto Co. v. Scruggs, Nos.
04-1532, 05-1120, 05-1121 (Fed. Cir. Sept. 26, 2005). Thus, it could be argued that this
alternative technique still imposes a use restriction, albeit one that does not require
additional purchases, as does Monsanto's policy in the United States.
356. See, e.g., Joined Cases C-267/95 & C-268/95, Merck & Co., Inc. v. Primecrown Ltd. &
Beecham Group plc v. Europharm of Worthing Ltd., 1996 E.C.R. 1-06285, 1996 ECJ CELEX
LEXIS 11067.
357. Case T-168/01, GlaxoSmithKline Servs. Unltd. v. Comm'n (27 Sept. 2006), available
at http://curia.europa.eu/jurisp/cgi-bin/form.pl?lang-EN&Submit=rechercher&numaffT-168/
01.
358. GlaxoSmithKline is not entirely an aberration. In the ECJ's decisions on rental rights
for videorecordings, the court has permitted copyright owners to prohibit the rentals in one
country of videorecordings purchased in another. The court has emphasized the importance
of a derogation from the exhaustion principle to the extent that it is necessary to ensure that
the videorecording owners were able to recover "remuneration ... which secures for them a
satisfactory share of the rental market." Case C-61/97, Foreningen af danske
Videogramdistributorer v. Laserdisken, 1998 E.C.R. 1-05171, 12; see Case 158/86, Warner
Bros. Inc. v. Christiansen, 1988 E.C.R. 02605.
359. GlaxoSmithKline, supra note 357 294-303.
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entirely clear how that balancing was to be performed, it imposed
on the Commission the burdens of evaluating the prospective
innovation benefits and of balancing those benefits against the
harms to competition of the territorial partitioning.36 ° The court also
emphasized the specific nature of the problems in the pharmaceuti-
cal market.36' Whether this model is applicable to specific problems
in U.S. patent law, such as those of self-replicating seeds, is unclear.
What seems certain is that allowing patentees to devise their own
solutions through contractual use restrictions is not likely to lead to
the best solutions.
CONCLUSION
There is widespread concern, at least in the United States, that
intellectual property protections have been extended too far.362 This
concern has focused primarily on contractual and statutory
limitations on the use of copyrighted materials363 and on the quality
of patent examination, which may lead to the issuing of many
questionable patents. The field-of-use licensing cases from the
United States discussed in this Article present a combination of
these problems. Like contractual extensions of copyright, the use-
licensing cases allow intellectual property owners to extend their
protection into areas not intended by the legislature, such as
product distribution.364 And like questionable patents, use licensing
can extend protection into areas that are unrelated to the patentee's
inventive contribution.365
Consequently, this Article calls for closer scrutiny of field-of-use
licensing with respect to both its contractual and patent law
elements. As with copyright, careful examination of the transaction
that is claimed to have ceded the purchaser's rights is necessary
to determine if a contract has been formed. More fundamentally,
it is critical to determine, even if there is a contract, whether the
360. Id. 241, 301, 304.
361. Id.
362. See, e.g., Harry First, Controlling the Intellectual Property Grab: Protect Innovation,
Not Innovators, 38 RUTGERs L.J. 365 (2007).
363. See supra text accompanying notes 15-24.
364. See supra Part II.A.2.
365. See supra Parts III.A.1-2.
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challenged conduct falls within the statutory definitions of patent
infringement. If not, the patentee may have a breach of contract
action. No contract, however, can transform permitted conduct into
patent infringement. Several U.S. courts have blended contractual
and patent law in a way that prevented careful analysis of either.
More careful scrutiny in both areas can restore appropriate limits
to patent protection.
